context stringlengths 21 33.9k | category stringclasses 2
values | entity stringlengths 1 12 | entity_type stringclasses 5
values | query stringlengths 97 3.31k | answer stringlengths 12 169 |
|---|---|---|---|---|---|
The Company has a defined contribution retirement plan covering the United States and other international full-time employees that provides for voluntary employee contributions from 1 % to 100 % of annual compensation, subject to a maximum limit allowed by Internal Revenue Service guidelines. In certain locations, the Company makes contributions to employee defined contribution plans, these contributions were $ 1.2 million, $ 0.9 million, and $ 0.8 million in 2024, 2023, and 2022, respectively. | text | 0.8 | monetaryItemType | text: <entity> 0.8 </entity> <entity type> monetaryItemType </entity type> <context> The Company has a defined contribution retirement plan covering the United States and other international full-time employees that provides for voluntary employee contributions from 1 % to 100 % of annual compensation, subject to a maximum limit allowed by Internal Revenue Service guidelines. In certain locations, the Company makes contributions to employee defined contribution plans, these contributions were $ 1.2 million, $ 0.9 million, and $ 0.8 million in 2024, 2023, and 2022, respectively. </context> | us-gaap:DefinedBenefitPlanContributionsByEmployer |
The weighted-average grant date fair value of all options granted was zero , $ 2.14 , and $ 5.05 per share in 2024, 2023, and 2022, respectively. The total fair value of all options vested was $ 0.8 million, $ 1.4 million, and $ 1.5 million in 2024, 2023, and 2022, respectively. The aggregate intrinsic value of the stock options outstanding as of | text | zero | perShareItemType | text: <entity> zero </entity> <entity type> perShareItemType </entity type> <context> The weighted-average grant date fair value of all options granted was zero , $ 2.14 , and $ 5.05 per share in 2024, 2023, and 2022, respectively. The total fair value of all options vested was $ 0.8 million, $ 1.4 million, and $ 1.5 million in 2024, 2023, and 2022, respectively. The aggregate intrinsic value of the stock options outstanding as of </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
The weighted-average grant date fair value of all options granted was zero , $ 2.14 , and $ 5.05 per share in 2024, 2023, and 2022, respectively. The total fair value of all options vested was $ 0.8 million, $ 1.4 million, and $ 1.5 million in 2024, 2023, and 2022, respectively. The aggregate intrinsic value of the stock options outstanding as of | text | 2.14 | perShareItemType | text: <entity> 2.14 </entity> <entity type> perShareItemType </entity type> <context> The weighted-average grant date fair value of all options granted was zero , $ 2.14 , and $ 5.05 per share in 2024, 2023, and 2022, respectively. The total fair value of all options vested was $ 0.8 million, $ 1.4 million, and $ 1.5 million in 2024, 2023, and 2022, respectively. The aggregate intrinsic value of the stock options outstanding as of </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
The weighted-average grant date fair value of all options granted was zero , $ 2.14 , and $ 5.05 per share in 2024, 2023, and 2022, respectively. The total fair value of all options vested was $ 0.8 million, $ 1.4 million, and $ 1.5 million in 2024, 2023, and 2022, respectively. The aggregate intrinsic value of the stock options outstanding as of | text | 5.05 | perShareItemType | text: <entity> 5.05 </entity> <entity type> perShareItemType </entity type> <context> The weighted-average grant date fair value of all options granted was zero , $ 2.14 , and $ 5.05 per share in 2024, 2023, and 2022, respectively. The total fair value of all options vested was $ 0.8 million, $ 1.4 million, and $ 1.5 million in 2024, 2023, and 2022, respectively. The aggregate intrinsic value of the stock options outstanding as of </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
The weighted-average grant date fair value of all options granted was zero , $ 2.14 , and $ 5.05 per share in 2024, 2023, and 2022, respectively. The total fair value of all options vested was $ 0.8 million, $ 1.4 million, and $ 1.5 million in 2024, 2023, and 2022, respectively. The aggregate intrinsic value of the stock options outstanding as of | text | 0.8 | monetaryItemType | text: <entity> 0.8 </entity> <entity type> monetaryItemType </entity type> <context> The weighted-average grant date fair value of all options granted was zero , $ 2.14 , and $ 5.05 per share in 2024, 2023, and 2022, respectively. The total fair value of all options vested was $ 0.8 million, $ 1.4 million, and $ 1.5 million in 2024, 2023, and 2022, respectively. The aggregate intrinsic value of the stock options outstanding as of </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 |
The weighted-average grant date fair value of all options granted was zero , $ 2.14 , and $ 5.05 per share in 2024, 2023, and 2022, respectively. The total fair value of all options vested was $ 0.8 million, $ 1.4 million, and $ 1.5 million in 2024, 2023, and 2022, respectively. The aggregate intrinsic value of the stock options outstanding as of | text | 1.4 | monetaryItemType | text: <entity> 1.4 </entity> <entity type> monetaryItemType </entity type> <context> The weighted-average grant date fair value of all options granted was zero , $ 2.14 , and $ 5.05 per share in 2024, 2023, and 2022, respectively. The total fair value of all options vested was $ 0.8 million, $ 1.4 million, and $ 1.5 million in 2024, 2023, and 2022, respectively. The aggregate intrinsic value of the stock options outstanding as of </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 |
The weighted-average grant date fair value of all options granted was zero , $ 2.14 , and $ 5.05 per share in 2024, 2023, and 2022, respectively. The total fair value of all options vested was $ 0.8 million, $ 1.4 million, and $ 1.5 million in 2024, 2023, and 2022, respectively. The aggregate intrinsic value of the stock options outstanding as of | text | 1.5 | monetaryItemType | text: <entity> 1.5 </entity> <entity type> monetaryItemType </entity type> <context> The weighted-average grant date fair value of all options granted was zero , $ 2.14 , and $ 5.05 per share in 2024, 2023, and 2022, respectively. The total fair value of all options vested was $ 0.8 million, $ 1.4 million, and $ 1.5 million in 2024, 2023, and 2022, respectively. The aggregate intrinsic value of the stock options outstanding as of </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 |
The weighted-average grant date fair value of all RSUs granted was $ 1.76 , $ 5.13 , and $ 7.68 per share in 2024, | text | 1.76 | perShareItemType | text: <entity> 1.76 </entity> <entity type> perShareItemType </entity type> <context> The weighted-average grant date fair value of all RSUs granted was $ 1.76 , $ 5.13 , and $ 7.68 per share in 2024, </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
The weighted-average grant date fair value of all RSUs granted was $ 1.76 , $ 5.13 , and $ 7.68 per share in 2024, | text | 5.13 | perShareItemType | text: <entity> 5.13 </entity> <entity type> perShareItemType </entity type> <context> The weighted-average grant date fair value of all RSUs granted was $ 1.76 , $ 5.13 , and $ 7.68 per share in 2024, </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
The weighted-average grant date fair value of all RSUs granted was $ 1.76 , $ 5.13 , and $ 7.68 per share in 2024, | text | 7.68 | perShareItemType | text: <entity> 7.68 </entity> <entity type> perShareItemType </entity type> <context> The weighted-average grant date fair value of all RSUs granted was $ 1.76 , $ 5.13 , and $ 7.68 per share in 2024, </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
2023, and 2022, respectively. The total fair value of all RSUs vested was $ 30.6 million, $ 34.5 million, and $ 30.8 million in 2024, 2023, and 2022, respectively. | text | 30.6 | monetaryItemType | text: <entity> 30.6 </entity> <entity type> monetaryItemType </entity type> <context> 2023, and 2022, respectively. The total fair value of all RSUs vested was $ 30.6 million, $ 34.5 million, and $ 30.8 million in 2024, 2023, and 2022, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue |
2023, and 2022, respectively. The total fair value of all RSUs vested was $ 30.6 million, $ 34.5 million, and $ 30.8 million in 2024, 2023, and 2022, respectively. | text | 34.5 | monetaryItemType | text: <entity> 34.5 </entity> <entity type> monetaryItemType </entity type> <context> 2023, and 2022, respectively. The total fair value of all RSUs vested was $ 30.6 million, $ 34.5 million, and $ 30.8 million in 2024, 2023, and 2022, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue |
2023, and 2022, respectively. The total fair value of all RSUs vested was $ 30.6 million, $ 34.5 million, and $ 30.8 million in 2024, 2023, and 2022, respectively. | text | 30.8 | monetaryItemType | text: <entity> 30.8 </entity> <entity type> monetaryItemType </entity type> <context> 2023, and 2022, respectively. The total fair value of all RSUs vested was $ 30.6 million, $ 34.5 million, and $ 30.8 million in 2024, 2023, and 2022, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue |
The weighted-average grant date fair value of all PSUs granted was $ 1.70 , $ 5.79 , and $ 8.70 per share in 2024, 2023, and 2022, respectively. The total fair value of all PSUs vested was $ 3.5 million, $ 3.7 million, and $ 4.8 million in 2024, 2023, and 2022, respectively. | text | 1.70 | monetaryItemType | text: <entity> 1.70 </entity> <entity type> monetaryItemType </entity type> <context> The weighted-average grant date fair value of all PSUs granted was $ 1.70 , $ 5.79 , and $ 8.70 per share in 2024, 2023, and 2022, respectively. The total fair value of all PSUs vested was $ 3.5 million, $ 3.7 million, and $ 4.8 million in 2024, 2023, and 2022, respectively. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 |
The weighted-average grant date fair value of all PSUs granted was $ 1.70 , $ 5.79 , and $ 8.70 per share in 2024, 2023, and 2022, respectively. The total fair value of all PSUs vested was $ 3.5 million, $ 3.7 million, and $ 4.8 million in 2024, 2023, and 2022, respectively. | text | 5.79 | monetaryItemType | text: <entity> 5.79 </entity> <entity type> monetaryItemType </entity type> <context> The weighted-average grant date fair value of all PSUs granted was $ 1.70 , $ 5.79 , and $ 8.70 per share in 2024, 2023, and 2022, respectively. The total fair value of all PSUs vested was $ 3.5 million, $ 3.7 million, and $ 4.8 million in 2024, 2023, and 2022, respectively. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 |
The weighted-average grant date fair value of all PSUs granted was $ 1.70 , $ 5.79 , and $ 8.70 per share in 2024, 2023, and 2022, respectively. The total fair value of all PSUs vested was $ 3.5 million, $ 3.7 million, and $ 4.8 million in 2024, 2023, and 2022, respectively. | text | 8.70 | monetaryItemType | text: <entity> 8.70 </entity> <entity type> monetaryItemType </entity type> <context> The weighted-average grant date fair value of all PSUs granted was $ 1.70 , $ 5.79 , and $ 8.70 per share in 2024, 2023, and 2022, respectively. The total fair value of all PSUs vested was $ 3.5 million, $ 3.7 million, and $ 4.8 million in 2024, 2023, and 2022, respectively. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 |
The weighted-average grant date fair value of all PSUs granted was $ 1.70 , $ 5.79 , and $ 8.70 per share in 2024, 2023, and 2022, respectively. The total fair value of all PSUs vested was $ 3.5 million, $ 3.7 million, and $ 4.8 million in 2024, 2023, and 2022, respectively. | text | 3.5 | monetaryItemType | text: <entity> 3.5 </entity> <entity type> monetaryItemType </entity type> <context> The weighted-average grant date fair value of all PSUs granted was $ 1.70 , $ 5.79 , and $ 8.70 per share in 2024, 2023, and 2022, respectively. The total fair value of all PSUs vested was $ 3.5 million, $ 3.7 million, and $ 4.8 million in 2024, 2023, and 2022, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue |
The weighted-average grant date fair value of all PSUs granted was $ 1.70 , $ 5.79 , and $ 8.70 per share in 2024, 2023, and 2022, respectively. The total fair value of all PSUs vested was $ 3.5 million, $ 3.7 million, and $ 4.8 million in 2024, 2023, and 2022, respectively. | text | 3.7 | monetaryItemType | text: <entity> 3.7 </entity> <entity type> monetaryItemType </entity type> <context> The weighted-average grant date fair value of all PSUs granted was $ 1.70 , $ 5.79 , and $ 8.70 per share in 2024, 2023, and 2022, respectively. The total fair value of all PSUs vested was $ 3.5 million, $ 3.7 million, and $ 4.8 million in 2024, 2023, and 2022, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue |
The weighted-average grant date fair value of all PSUs granted was $ 1.70 , $ 5.79 , and $ 8.70 per share in 2024, 2023, and 2022, respectively. The total fair value of all PSUs vested was $ 3.5 million, $ 3.7 million, and $ 4.8 million in 2024, 2023, and 2022, respectively. | text | 4.8 | monetaryItemType | text: <entity> 4.8 </entity> <entity type> monetaryItemType </entity type> <context> The weighted-average grant date fair value of all PSUs granted was $ 1.70 , $ 5.79 , and $ 8.70 per share in 2024, 2023, and 2022, respectively. The total fair value of all PSUs vested was $ 3.5 million, $ 3.7 million, and $ 4.8 million in 2024, 2023, and 2022, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue |
2024, 2023, and 2022 the Company issued 1.4 million, 0.9 million, and 0.7 million shares under its employee stock purchase plans, respectively, at weighted-average prices of $ 1.56 , $ 4.10 , and $ 6.72 per share, respectively. | text | 1.4 | sharesItemType | text: <entity> 1.4 </entity> <entity type> sharesItemType </entity type> <context> 2024, 2023, and 2022 the Company issued 1.4 million, 0.9 million, and 0.7 million shares under its employee stock purchase plans, respectively, at weighted-average prices of $ 1.56 , $ 4.10 , and $ 6.72 per share, respectively. </context> | us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans |
2024, 2023, and 2022 the Company issued 1.4 million, 0.9 million, and 0.7 million shares under its employee stock purchase plans, respectively, at weighted-average prices of $ 1.56 , $ 4.10 , and $ 6.72 per share, respectively. | text | 0.9 | sharesItemType | text: <entity> 0.9 </entity> <entity type> sharesItemType </entity type> <context> 2024, 2023, and 2022 the Company issued 1.4 million, 0.9 million, and 0.7 million shares under its employee stock purchase plans, respectively, at weighted-average prices of $ 1.56 , $ 4.10 , and $ 6.72 per share, respectively. </context> | us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans |
2024, 2023, and 2022 the Company issued 1.4 million, 0.9 million, and 0.7 million shares under its employee stock purchase plans, respectively, at weighted-average prices of $ 1.56 , $ 4.10 , and $ 6.72 per share, respectively. | text | 0.7 | sharesItemType | text: <entity> 0.7 </entity> <entity type> sharesItemType </entity type> <context> 2024, 2023, and 2022 the Company issued 1.4 million, 0.9 million, and 0.7 million shares under its employee stock purchase plans, respectively, at weighted-average prices of $ 1.56 , $ 4.10 , and $ 6.72 per share, respectively. </context> | us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans |
2024, 2023, and 2022 the Company issued 1.4 million, 0.9 million, and 0.7 million shares under its employee stock purchase plans, respectively, at weighted-average prices of $ 1.56 , $ 4.10 , and $ 6.72 per share, respectively. | text | 1.56 | perShareItemType | text: <entity> 1.56 </entity> <entity type> perShareItemType </entity type> <context> 2024, 2023, and 2022 the Company issued 1.4 million, 0.9 million, and 0.7 million shares under its employee stock purchase plans, respectively, at weighted-average prices of $ 1.56 , $ 4.10 , and $ 6.72 per share, respectively. </context> | us-gaap:EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased |
2024, 2023, and 2022 the Company issued 1.4 million, 0.9 million, and 0.7 million shares under its employee stock purchase plans, respectively, at weighted-average prices of $ 1.56 , $ 4.10 , and $ 6.72 per share, respectively. | text | 4.10 | perShareItemType | text: <entity> 4.10 </entity> <entity type> perShareItemType </entity type> <context> 2024, 2023, and 2022 the Company issued 1.4 million, 0.9 million, and 0.7 million shares under its employee stock purchase plans, respectively, at weighted-average prices of $ 1.56 , $ 4.10 , and $ 6.72 per share, respectively. </context> | us-gaap:EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased |
2024, 2023, and 2022 the Company issued 1.4 million, 0.9 million, and 0.7 million shares under its employee stock purchase plans, respectively, at weighted-average prices of $ 1.56 , $ 4.10 , and $ 6.72 per share, respectively. | text | 6.72 | perShareItemType | text: <entity> 6.72 </entity> <entity type> perShareItemType </entity type> <context> 2024, 2023, and 2022 the Company issued 1.4 million, 0.9 million, and 0.7 million shares under its employee stock purchase plans, respectively, at weighted-average prices of $ 1.56 , $ 4.10 , and $ 6.72 per share, respectively. </context> | us-gaap:EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased |
There was no income tax benefit related to stock-based compensation expense for the year ended December 31, 2024 due to a full valuation allowance on the Company’s United States net deferred tax assets. The income tax benefit related to stock-based compensation expense was $ 9.3 million and $ 8.6 million for the year ended December 31, 2023 and 2022, respectively. See Note 9, Income taxes, for additional details. | text | no | monetaryItemType | text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> There was no income tax benefit related to stock-based compensation expense for the year ended December 31, 2024 due to a full valuation allowance on the Company’s United States net deferred tax assets. The income tax benefit related to stock-based compensation expense was $ 9.3 million and $ 8.6 million for the year ended December 31, 2023 and 2022, respectively. See Note 9, Income taxes, for additional details. </context> | us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense |
There was no income tax benefit related to stock-based compensation expense for the year ended December 31, 2024 due to a full valuation allowance on the Company’s United States net deferred tax assets. The income tax benefit related to stock-based compensation expense was $ 9.3 million and $ 8.6 million for the year ended December 31, 2023 and 2022, respectively. See Note 9, Income taxes, for additional details. | text | 9.3 | monetaryItemType | text: <entity> 9.3 </entity> <entity type> monetaryItemType </entity type> <context> There was no income tax benefit related to stock-based compensation expense for the year ended December 31, 2024 due to a full valuation allowance on the Company’s United States net deferred tax assets. The income tax benefit related to stock-based compensation expense was $ 9.3 million and $ 8.6 million for the year ended December 31, 2023 and 2022, respectively. See Note 9, Income taxes, for additional details. </context> | us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense |
There was no income tax benefit related to stock-based compensation expense for the year ended December 31, 2024 due to a full valuation allowance on the Company’s United States net deferred tax assets. The income tax benefit related to stock-based compensation expense was $ 9.3 million and $ 8.6 million for the year ended December 31, 2023 and 2022, respectively. See Note 9, Income taxes, for additional details. | text | 8.6 | monetaryItemType | text: <entity> 8.6 </entity> <entity type> monetaryItemType </entity type> <context> There was no income tax benefit related to stock-based compensation expense for the year ended December 31, 2024 due to a full valuation allowance on the Company’s United States net deferred tax assets. The income tax benefit related to stock-based compensation expense was $ 9.3 million and $ 8.6 million for the year ended December 31, 2023 and 2022, respectively. See Note 9, Income taxes, for additional details. </context> | us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense |
The 2025 Notes will mature on November 15, 2025, unless earlier repurchased or converted into shares of Class A common stock under certain circumstances as described further in Note 5 Financing arrangements. Prior to August 15, 2025, the 2025 Notes are convertible at the option of the holder, at an initial conversion rate of 107.1984 shares of Class A common stock per $ 1,000 principal amount of the 2025 Notes, which is equivalent to an initial conversion price of approximately $ 9.3285 per share of common stock, subject to adjustment. Conversion will be settled in cash, shares of the Company’s Class A common stock, or a combination thereof, at the Company’s election. | text | 9.3285 | perShareItemType | text: <entity> 9.3285 </entity> <entity type> perShareItemType </entity type> <context> The 2025 Notes will mature on November 15, 2025, unless earlier repurchased or converted into shares of Class A common stock under certain circumstances as described further in Note 5 Financing arrangements. Prior to August 15, 2025, the 2025 Notes are convertible at the option of the holder, at an initial conversion rate of 107.1984 shares of Class A common stock per $ 1,000 principal amount of the 2025 Notes, which is equivalent to an initial conversion price of approximately $ 9.3285 per share of common stock, subject to adjustment. Conversion will be settled in cash, shares of the Company’s Class A common stock, or a combination thereof, at the Company’s election. </context> | us-gaap:DebtInstrumentConvertibleConversionPrice1 |
The rights of the holders of Class A common stock and Class B common stock are identical, except with respect to voting and conversion. Each share of Class A common stock is entitled to one vote per share and each share of Class B common stock is entitled to ten votes per share. Each share of Class B common stock is convertible at any time at the option of the stockholder into one share of Class A common stock and has no expiration date. Each share of Class B common stock will convert automatically into one share of Class A common stock upon the date when the outstanding shares of Class B common stock represent less than 10 % of the aggregate number of shares of common stock then outstanding. Class A common stock is not convertible into Class B common stock. The computation of the diluted net income per share of Class A common stock assumes the conversion of Class B common stock. | text | one | sharesItemType | text: <entity> one </entity> <entity type> sharesItemType </entity type> <context> The rights of the holders of Class A common stock and Class B common stock are identical, except with respect to voting and conversion. Each share of Class A common stock is entitled to one vote per share and each share of Class B common stock is entitled to ten votes per share. Each share of Class B common stock is convertible at any time at the option of the stockholder into one share of Class A common stock and has no expiration date. Each share of Class B common stock will convert automatically into one share of Class A common stock upon the date when the outstanding shares of Class B common stock represent less than 10 % of the aggregate number of shares of common stock then outstanding. Class A common stock is not convertible into Class B common stock. The computation of the diluted net income per share of Class A common stock assumes the conversion of Class B common stock. </context> | us-gaap:ConversionOfStockSharesIssued1 |
The negative effective tax rate of 224.8 % for 2024, primarily resulted from the establishment and the current year change in the valuation allowance on the United States federal and state net deferred tax assets, partially offset by a tax benefit on a pre-tax net loss, and the release of a portion of uncertain tax positions as a result of a lapse in the statute of limitations in certain jurisdictions. The effective tax rate of 21.5 % for 2023, primarily resulted from a tax benefit on pre-tax book loss, and federal and California research and development credits, partially offset by the nondeductible equity tax expense from stock-based compensation and the impact of foreign operations, net of the release of a portion of uncertain tax positions as a result of a lapse in the statute of limitations in certain jurisdictions. | text | 224.8 | percentItemType | text: <entity> 224.8 </entity> <entity type> percentItemType </entity type> <context> The negative effective tax rate of 224.8 % for 2024, primarily resulted from the establishment and the current year change in the valuation allowance on the United States federal and state net deferred tax assets, partially offset by a tax benefit on a pre-tax net loss, and the release of a portion of uncertain tax positions as a result of a lapse in the statute of limitations in certain jurisdictions. The effective tax rate of 21.5 % for 2023, primarily resulted from a tax benefit on pre-tax book loss, and federal and California research and development credits, partially offset by the nondeductible equity tax expense from stock-based compensation and the impact of foreign operations, net of the release of a portion of uncertain tax positions as a result of a lapse in the statute of limitations in certain jurisdictions. </context> | us-gaap:EffectiveIncomeTaxRateContinuingOperations |
The negative effective tax rate of 224.8 % for 2024, primarily resulted from the establishment and the current year change in the valuation allowance on the United States federal and state net deferred tax assets, partially offset by a tax benefit on a pre-tax net loss, and the release of a portion of uncertain tax positions as a result of a lapse in the statute of limitations in certain jurisdictions. The effective tax rate of 21.5 % for 2023, primarily resulted from a tax benefit on pre-tax book loss, and federal and California research and development credits, partially offset by the nondeductible equity tax expense from stock-based compensation and the impact of foreign operations, net of the release of a portion of uncertain tax positions as a result of a lapse in the statute of limitations in certain jurisdictions. | text | 21.5 | percentItemType | text: <entity> 21.5 </entity> <entity type> percentItemType </entity type> <context> The negative effective tax rate of 224.8 % for 2024, primarily resulted from the establishment and the current year change in the valuation allowance on the United States federal and state net deferred tax assets, partially offset by a tax benefit on a pre-tax net loss, and the release of a portion of uncertain tax positions as a result of a lapse in the statute of limitations in certain jurisdictions. The effective tax rate of 21.5 % for 2023, primarily resulted from a tax benefit on pre-tax book loss, and federal and California research and development credits, partially offset by the nondeductible equity tax expense from stock-based compensation and the impact of foreign operations, net of the release of a portion of uncertain tax positions as a result of a lapse in the statute of limitations in certain jurisdictions. </context> | us-gaap:EffectiveIncomeTaxRateContinuingOperations |
Each quarter, the Company assesses the realizability of its existing deferred tax assets under ASC Topic 740. The Company assesses available positive and negative evidence to estimate whether sufficient future taxable income will be generated to realize its deferred tax assets. In the assessment for the period ended March 31, 2024, the Company concluded based on the introduction of negative evidence resulting from developments in the first quarter of 2024, such as increased and accelerated costs associated with the Company’s future product strategy and roadmap, an increased competitive environment, integration and product development costs related to the acquisition of Forcite Helmet Systems, restructuring costs and other negative factors, that it was more likely than not that its United States federal and state deferred tax assets would not be realizable. Therefore, in the period ended March 31, 2024, after consideration of the Company’s deferred tax liabilities and recent developments, the Company provided a valuation allowance of $ 294.9 million on United States federal and state deferred tax assets. That determination was also based, in part, on the Company’s revised expectation that its projections of pre-tax losses in 2024 and future years will cause the Company to be in a cumulative GAAP loss for ASC Topic 740 purposes in 2024 and forward. In the assessment for the period ended December 31, 2024, the Company concluded that it remains more likely than not that the Company will not be able to realize its deferred tax assets. As of December 31, 2024, the total valuation allowance on United States federal and state net deferred tax assets was $ 327.4 million. The Company will continue to monitor its future financial results, expected projections and their potential impact on the Company’s assessment regarding the recoverability of its deferred tax asset balances and in the event there is a need to release the valuation allowance, a tax benefit would be recorded. The Company’s foreign deferred tax assets in each jurisdiction are supported by taxable income or in the case of acquired companies, by the future reversal of deferred tax liabilities. It is more likely than not that the Company’s foreign deferred tax assets will be realized and thus, a valuation allowance is not required on its foreign deferred tax assets. | text | 294.9 | monetaryItemType | text: <entity> 294.9 </entity> <entity type> monetaryItemType </entity type> <context> Each quarter, the Company assesses the realizability of its existing deferred tax assets under ASC Topic 740. The Company assesses available positive and negative evidence to estimate whether sufficient future taxable income will be generated to realize its deferred tax assets. In the assessment for the period ended March 31, 2024, the Company concluded based on the introduction of negative evidence resulting from developments in the first quarter of 2024, such as increased and accelerated costs associated with the Company’s future product strategy and roadmap, an increased competitive environment, integration and product development costs related to the acquisition of Forcite Helmet Systems, restructuring costs and other negative factors, that it was more likely than not that its United States federal and state deferred tax assets would not be realizable. Therefore, in the period ended March 31, 2024, after consideration of the Company’s deferred tax liabilities and recent developments, the Company provided a valuation allowance of $ 294.9 million on United States federal and state deferred tax assets. That determination was also based, in part, on the Company’s revised expectation that its projections of pre-tax losses in 2024 and future years will cause the Company to be in a cumulative GAAP loss for ASC Topic 740 purposes in 2024 and forward. In the assessment for the period ended December 31, 2024, the Company concluded that it remains more likely than not that the Company will not be able to realize its deferred tax assets. As of December 31, 2024, the total valuation allowance on United States federal and state net deferred tax assets was $ 327.4 million. The Company will continue to monitor its future financial results, expected projections and their potential impact on the Company’s assessment regarding the recoverability of its deferred tax asset balances and in the event there is a need to release the valuation allowance, a tax benefit would be recorded. The Company’s foreign deferred tax assets in each jurisdiction are supported by taxable income or in the case of acquired companies, by the future reversal of deferred tax liabilities. It is more likely than not that the Company’s foreign deferred tax assets will be realized and thus, a valuation allowance is not required on its foreign deferred tax assets. </context> | us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount |
Each quarter, the Company assesses the realizability of its existing deferred tax assets under ASC Topic 740. The Company assesses available positive and negative evidence to estimate whether sufficient future taxable income will be generated to realize its deferred tax assets. In the assessment for the period ended March 31, 2024, the Company concluded based on the introduction of negative evidence resulting from developments in the first quarter of 2024, such as increased and accelerated costs associated with the Company’s future product strategy and roadmap, an increased competitive environment, integration and product development costs related to the acquisition of Forcite Helmet Systems, restructuring costs and other negative factors, that it was more likely than not that its United States federal and state deferred tax assets would not be realizable. Therefore, in the period ended March 31, 2024, after consideration of the Company’s deferred tax liabilities and recent developments, the Company provided a valuation allowance of $ 294.9 million on United States federal and state deferred tax assets. That determination was also based, in part, on the Company’s revised expectation that its projections of pre-tax losses in 2024 and future years will cause the Company to be in a cumulative GAAP loss for ASC Topic 740 purposes in 2024 and forward. In the assessment for the period ended December 31, 2024, the Company concluded that it remains more likely than not that the Company will not be able to realize its deferred tax assets. As of December 31, 2024, the total valuation allowance on United States federal and state net deferred tax assets was $ 327.4 million. The Company will continue to monitor its future financial results, expected projections and their potential impact on the Company’s assessment regarding the recoverability of its deferred tax asset balances and in the event there is a need to release the valuation allowance, a tax benefit would be recorded. The Company’s foreign deferred tax assets in each jurisdiction are supported by taxable income or in the case of acquired companies, by the future reversal of deferred tax liabilities. It is more likely than not that the Company’s foreign deferred tax assets will be realized and thus, a valuation allowance is not required on its foreign deferred tax assets. | text | 327.4 | monetaryItemType | text: <entity> 327.4 </entity> <entity type> monetaryItemType </entity type> <context> Each quarter, the Company assesses the realizability of its existing deferred tax assets under ASC Topic 740. The Company assesses available positive and negative evidence to estimate whether sufficient future taxable income will be generated to realize its deferred tax assets. In the assessment for the period ended March 31, 2024, the Company concluded based on the introduction of negative evidence resulting from developments in the first quarter of 2024, such as increased and accelerated costs associated with the Company’s future product strategy and roadmap, an increased competitive environment, integration and product development costs related to the acquisition of Forcite Helmet Systems, restructuring costs and other negative factors, that it was more likely than not that its United States federal and state deferred tax assets would not be realizable. Therefore, in the period ended March 31, 2024, after consideration of the Company’s deferred tax liabilities and recent developments, the Company provided a valuation allowance of $ 294.9 million on United States federal and state deferred tax assets. That determination was also based, in part, on the Company’s revised expectation that its projections of pre-tax losses in 2024 and future years will cause the Company to be in a cumulative GAAP loss for ASC Topic 740 purposes in 2024 and forward. In the assessment for the period ended December 31, 2024, the Company concluded that it remains more likely than not that the Company will not be able to realize its deferred tax assets. As of December 31, 2024, the total valuation allowance on United States federal and state net deferred tax assets was $ 327.4 million. The Company will continue to monitor its future financial results, expected projections and their potential impact on the Company’s assessment regarding the recoverability of its deferred tax asset balances and in the event there is a need to release the valuation allowance, a tax benefit would be recorded. The Company’s foreign deferred tax assets in each jurisdiction are supported by taxable income or in the case of acquired companies, by the future reversal of deferred tax liabilities. It is more likely than not that the Company’s foreign deferred tax assets will be realized and thus, a valuation allowance is not required on its foreign deferred tax assets. </context> | us-gaap:DeferredTaxAssetsValuationAllowance |
As of December 31, 2024, the Company’s federal, California, and other state net operating loss carryforwards for income tax purposes were $ 396.6 million, $ 254.6 million, and $ 182.8 million, net of reserves, respectively. Also, the Company’s federal and California state tax credit carryforwards were $ 57.2 million and $ 56.6 million, net of reserves, respectively. If not utilized, federal net operating losses that arose before 2018 and California loss carryforwards will begin to expire from 2035 to 2044, while federal credit and other state loss carryforwards will begin to expire primarily from 2025 to 2044. Federal net operating losses that arose after 2017 and all California tax credits will be carried forward indefinitely. | text | 396.6 | monetaryItemType | text: <entity> 396.6 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company’s federal, California, and other state net operating loss carryforwards for income tax purposes were $ 396.6 million, $ 254.6 million, and $ 182.8 million, net of reserves, respectively. Also, the Company’s federal and California state tax credit carryforwards were $ 57.2 million and $ 56.6 million, net of reserves, respectively. If not utilized, federal net operating losses that arose before 2018 and California loss carryforwards will begin to expire from 2035 to 2044, while federal credit and other state loss carryforwards will begin to expire primarily from 2025 to 2044. Federal net operating losses that arose after 2017 and all California tax credits will be carried forward indefinitely. </context> | us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic |
As of December 31, 2024, the Company’s federal, California, and other state net operating loss carryforwards for income tax purposes were $ 396.6 million, $ 254.6 million, and $ 182.8 million, net of reserves, respectively. Also, the Company’s federal and California state tax credit carryforwards were $ 57.2 million and $ 56.6 million, net of reserves, respectively. If not utilized, federal net operating losses that arose before 2018 and California loss carryforwards will begin to expire from 2035 to 2044, while federal credit and other state loss carryforwards will begin to expire primarily from 2025 to 2044. Federal net operating losses that arose after 2017 and all California tax credits will be carried forward indefinitely. | text | 254.6 | monetaryItemType | text: <entity> 254.6 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company’s federal, California, and other state net operating loss carryforwards for income tax purposes were $ 396.6 million, $ 254.6 million, and $ 182.8 million, net of reserves, respectively. Also, the Company’s federal and California state tax credit carryforwards were $ 57.2 million and $ 56.6 million, net of reserves, respectively. If not utilized, federal net operating losses that arose before 2018 and California loss carryforwards will begin to expire from 2035 to 2044, while federal credit and other state loss carryforwards will begin to expire primarily from 2025 to 2044. Federal net operating losses that arose after 2017 and all California tax credits will be carried forward indefinitely. </context> | us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal |
As of December 31, 2024, the Company’s federal, California, and other state net operating loss carryforwards for income tax purposes were $ 396.6 million, $ 254.6 million, and $ 182.8 million, net of reserves, respectively. Also, the Company’s federal and California state tax credit carryforwards were $ 57.2 million and $ 56.6 million, net of reserves, respectively. If not utilized, federal net operating losses that arose before 2018 and California loss carryforwards will begin to expire from 2035 to 2044, while federal credit and other state loss carryforwards will begin to expire primarily from 2025 to 2044. Federal net operating losses that arose after 2017 and all California tax credits will be carried forward indefinitely. | text | 182.8 | monetaryItemType | text: <entity> 182.8 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company’s federal, California, and other state net operating loss carryforwards for income tax purposes were $ 396.6 million, $ 254.6 million, and $ 182.8 million, net of reserves, respectively. Also, the Company’s federal and California state tax credit carryforwards were $ 57.2 million and $ 56.6 million, net of reserves, respectively. If not utilized, federal net operating losses that arose before 2018 and California loss carryforwards will begin to expire from 2035 to 2044, while federal credit and other state loss carryforwards will begin to expire primarily from 2025 to 2044. Federal net operating losses that arose after 2017 and all California tax credits will be carried forward indefinitely. </context> | us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal |
As of December 31, 2024, the Company’s federal, California, and other state net operating loss carryforwards for income tax purposes were $ 396.6 million, $ 254.6 million, and $ 182.8 million, net of reserves, respectively. Also, the Company’s federal and California state tax credit carryforwards were $ 57.2 million and $ 56.6 million, net of reserves, respectively. If not utilized, federal net operating losses that arose before 2018 and California loss carryforwards will begin to expire from 2035 to 2044, while federal credit and other state loss carryforwards will begin to expire primarily from 2025 to 2044. Federal net operating losses that arose after 2017 and all California tax credits will be carried forward indefinitely. | text | 57.2 | monetaryItemType | text: <entity> 57.2 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company’s federal, California, and other state net operating loss carryforwards for income tax purposes were $ 396.6 million, $ 254.6 million, and $ 182.8 million, net of reserves, respectively. Also, the Company’s federal and California state tax credit carryforwards were $ 57.2 million and $ 56.6 million, net of reserves, respectively. If not utilized, federal net operating losses that arose before 2018 and California loss carryforwards will begin to expire from 2035 to 2044, while federal credit and other state loss carryforwards will begin to expire primarily from 2025 to 2044. Federal net operating losses that arose after 2017 and all California tax credits will be carried forward indefinitely. </context> | us-gaap:TaxCreditCarryforwardAmount |
As of December 31, 2024, the Company’s federal, California, and other state net operating loss carryforwards for income tax purposes were $ 396.6 million, $ 254.6 million, and $ 182.8 million, net of reserves, respectively. Also, the Company’s federal and California state tax credit carryforwards were $ 57.2 million and $ 56.6 million, net of reserves, respectively. If not utilized, federal net operating losses that arose before 2018 and California loss carryforwards will begin to expire from 2035 to 2044, while federal credit and other state loss carryforwards will begin to expire primarily from 2025 to 2044. Federal net operating losses that arose after 2017 and all California tax credits will be carried forward indefinitely. | text | 56.6 | monetaryItemType | text: <entity> 56.6 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company’s federal, California, and other state net operating loss carryforwards for income tax purposes were $ 396.6 million, $ 254.6 million, and $ 182.8 million, net of reserves, respectively. Also, the Company’s federal and California state tax credit carryforwards were $ 57.2 million and $ 56.6 million, net of reserves, respectively. If not utilized, federal net operating losses that arose before 2018 and California loss carryforwards will begin to expire from 2035 to 2044, while federal credit and other state loss carryforwards will begin to expire primarily from 2025 to 2044. Federal net operating losses that arose after 2017 and all California tax credits will be carried forward indefinitely. </context> | us-gaap:TaxCreditCarryforwardAmount |
The Company had gross unrecognized tax benefits of $ 27.0 million, $ 25.8 million, and $ 23.4 million, as of December 31, 2024, 2023, and 2022, respectively. For fiscal year 2024, 2023, and 2022, total unrecognized income tax benefits were $ 11.6 million, $ 10.9 million, and $ 9.8 million, respectively, and if recognized, would reduce income tax expense. A material portion of the Company’s gross unrecognized tax benefits, if recognized, would increase the Company’s net operating loss carryforward. | text | 27.0 | monetaryItemType | text: <entity> 27.0 </entity> <entity type> monetaryItemType </entity type> <context> The Company had gross unrecognized tax benefits of $ 27.0 million, $ 25.8 million, and $ 23.4 million, as of December 31, 2024, 2023, and 2022, respectively. For fiscal year 2024, 2023, and 2022, total unrecognized income tax benefits were $ 11.6 million, $ 10.9 million, and $ 9.8 million, respectively, and if recognized, would reduce income tax expense. A material portion of the Company’s gross unrecognized tax benefits, if recognized, would increase the Company’s net operating loss carryforward. </context> | us-gaap:UnrecognizedTaxBenefits |
The Company had gross unrecognized tax benefits of $ 27.0 million, $ 25.8 million, and $ 23.4 million, as of December 31, 2024, 2023, and 2022, respectively. For fiscal year 2024, 2023, and 2022, total unrecognized income tax benefits were $ 11.6 million, $ 10.9 million, and $ 9.8 million, respectively, and if recognized, would reduce income tax expense. A material portion of the Company’s gross unrecognized tax benefits, if recognized, would increase the Company’s net operating loss carryforward. | text | 25.8 | monetaryItemType | text: <entity> 25.8 </entity> <entity type> monetaryItemType </entity type> <context> The Company had gross unrecognized tax benefits of $ 27.0 million, $ 25.8 million, and $ 23.4 million, as of December 31, 2024, 2023, and 2022, respectively. For fiscal year 2024, 2023, and 2022, total unrecognized income tax benefits were $ 11.6 million, $ 10.9 million, and $ 9.8 million, respectively, and if recognized, would reduce income tax expense. A material portion of the Company’s gross unrecognized tax benefits, if recognized, would increase the Company’s net operating loss carryforward. </context> | us-gaap:UnrecognizedTaxBenefits |
The Company had gross unrecognized tax benefits of $ 27.0 million, $ 25.8 million, and $ 23.4 million, as of December 31, 2024, 2023, and 2022, respectively. For fiscal year 2024, 2023, and 2022, total unrecognized income tax benefits were $ 11.6 million, $ 10.9 million, and $ 9.8 million, respectively, and if recognized, would reduce income tax expense. A material portion of the Company’s gross unrecognized tax benefits, if recognized, would increase the Company’s net operating loss carryforward. | text | 23.4 | monetaryItemType | text: <entity> 23.4 </entity> <entity type> monetaryItemType </entity type> <context> The Company had gross unrecognized tax benefits of $ 27.0 million, $ 25.8 million, and $ 23.4 million, as of December 31, 2024, 2023, and 2022, respectively. For fiscal year 2024, 2023, and 2022, total unrecognized income tax benefits were $ 11.6 million, $ 10.9 million, and $ 9.8 million, respectively, and if recognized, would reduce income tax expense. A material portion of the Company’s gross unrecognized tax benefits, if recognized, would increase the Company’s net operating loss carryforward. </context> | us-gaap:UnrecognizedTaxBenefits |
The Company had gross unrecognized tax benefits of $ 27.0 million, $ 25.8 million, and $ 23.4 million, as of December 31, 2024, 2023, and 2022, respectively. For fiscal year 2024, 2023, and 2022, total unrecognized income tax benefits were $ 11.6 million, $ 10.9 million, and $ 9.8 million, respectively, and if recognized, would reduce income tax expense. A material portion of the Company’s gross unrecognized tax benefits, if recognized, would increase the Company’s net operating loss carryforward. | text | 11.6 | monetaryItemType | text: <entity> 11.6 </entity> <entity type> monetaryItemType </entity type> <context> The Company had gross unrecognized tax benefits of $ 27.0 million, $ 25.8 million, and $ 23.4 million, as of December 31, 2024, 2023, and 2022, respectively. For fiscal year 2024, 2023, and 2022, total unrecognized income tax benefits were $ 11.6 million, $ 10.9 million, and $ 9.8 million, respectively, and if recognized, would reduce income tax expense. A material portion of the Company’s gross unrecognized tax benefits, if recognized, would increase the Company’s net operating loss carryforward. </context> | us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate |
The Company had gross unrecognized tax benefits of $ 27.0 million, $ 25.8 million, and $ 23.4 million, as of December 31, 2024, 2023, and 2022, respectively. For fiscal year 2024, 2023, and 2022, total unrecognized income tax benefits were $ 11.6 million, $ 10.9 million, and $ 9.8 million, respectively, and if recognized, would reduce income tax expense. A material portion of the Company’s gross unrecognized tax benefits, if recognized, would increase the Company’s net operating loss carryforward. | text | 10.9 | monetaryItemType | text: <entity> 10.9 </entity> <entity type> monetaryItemType </entity type> <context> The Company had gross unrecognized tax benefits of $ 27.0 million, $ 25.8 million, and $ 23.4 million, as of December 31, 2024, 2023, and 2022, respectively. For fiscal year 2024, 2023, and 2022, total unrecognized income tax benefits were $ 11.6 million, $ 10.9 million, and $ 9.8 million, respectively, and if recognized, would reduce income tax expense. A material portion of the Company’s gross unrecognized tax benefits, if recognized, would increase the Company’s net operating loss carryforward. </context> | us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate |
The Company had gross unrecognized tax benefits of $ 27.0 million, $ 25.8 million, and $ 23.4 million, as of December 31, 2024, 2023, and 2022, respectively. For fiscal year 2024, 2023, and 2022, total unrecognized income tax benefits were $ 11.6 million, $ 10.9 million, and $ 9.8 million, respectively, and if recognized, would reduce income tax expense. A material portion of the Company’s gross unrecognized tax benefits, if recognized, would increase the Company’s net operating loss carryforward. | text | 9.8 | monetaryItemType | text: <entity> 9.8 </entity> <entity type> monetaryItemType </entity type> <context> The Company had gross unrecognized tax benefits of $ 27.0 million, $ 25.8 million, and $ 23.4 million, as of December 31, 2024, 2023, and 2022, respectively. For fiscal year 2024, 2023, and 2022, total unrecognized income tax benefits were $ 11.6 million, $ 10.9 million, and $ 9.8 million, respectively, and if recognized, would reduce income tax expense. A material portion of the Company’s gross unrecognized tax benefits, if recognized, would increase the Company’s net operating loss carryforward. </context> | us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate |
The Company conducts business globally and as a result, files income tax returns in the United States and foreign jurisdictions. The Company’s unrecognized tax benefits relate primarily to unresolved matters with taxing authorities. While it is often difficult to predict the final outcome or the timing of resolution of any particular uncertain tax position, the Company believes that its reserves reflect the more likely outcome. The Company believes, due to statute of limitations expiration, that within the next 12 months, it is possible that up to $ 2.9 million of uncertain tax positions could be released resulting in a tax benefit. It is also reasonably possible that additional uncertain tax positions will be added. It is not reasonably possible at this time to quantify the net effect. | text | 2.9 | monetaryItemType | text: <entity> 2.9 </entity> <entity type> monetaryItemType </entity type> <context> The Company conducts business globally and as a result, files income tax returns in the United States and foreign jurisdictions. The Company’s unrecognized tax benefits relate primarily to unresolved matters with taxing authorities. While it is often difficult to predict the final outcome or the timing of resolution of any particular uncertain tax position, the Company believes that its reserves reflect the more likely outcome. The Company believes, due to statute of limitations expiration, that within the next 12 months, it is possible that up to $ 2.9 million of uncertain tax positions could be released resulting in a tax benefit. It is also reasonably possible that additional uncertain tax positions will be added. It is not reasonably possible at this time to quantify the net effect. </context> | us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit |
Revenue from the United States, which is included in the Americas geographic region, was $ 291.3 million, $ 388.0 million, and $ 446.0 million for 2024, 2023, and 2022 respectively. No other individual country exceeded 10% of total revenue for any period presented. The Company does not disclose revenue by product category as it does not track sales incentives and other revenue adjustments by product category to report such data. | text | 291.3 | monetaryItemType | text: <entity> 291.3 </entity> <entity type> monetaryItemType </entity type> <context> Revenue from the United States, which is included in the Americas geographic region, was $ 291.3 million, $ 388.0 million, and $ 446.0 million for 2024, 2023, and 2022 respectively. No other individual country exceeded 10% of total revenue for any period presented. The Company does not disclose revenue by product category as it does not track sales incentives and other revenue adjustments by product category to report such data. </context> | us-gaap:Revenues |
Revenue from the United States, which is included in the Americas geographic region, was $ 291.3 million, $ 388.0 million, and $ 446.0 million for 2024, 2023, and 2022 respectively. No other individual country exceeded 10% of total revenue for any period presented. The Company does not disclose revenue by product category as it does not track sales incentives and other revenue adjustments by product category to report such data. | text | 388.0 | monetaryItemType | text: <entity> 388.0 </entity> <entity type> monetaryItemType </entity type> <context> Revenue from the United States, which is included in the Americas geographic region, was $ 291.3 million, $ 388.0 million, and $ 446.0 million for 2024, 2023, and 2022 respectively. No other individual country exceeded 10% of total revenue for any period presented. The Company does not disclose revenue by product category as it does not track sales incentives and other revenue adjustments by product category to report such data. </context> | us-gaap:Revenues |
Revenue from the United States, which is included in the Americas geographic region, was $ 291.3 million, $ 388.0 million, and $ 446.0 million for 2024, 2023, and 2022 respectively. No other individual country exceeded 10% of total revenue for any period presented. The Company does not disclose revenue by product category as it does not track sales incentives and other revenue adjustments by product category to report such data. | text | 446.0 | monetaryItemType | text: <entity> 446.0 </entity> <entity type> monetaryItemType </entity type> <context> Revenue from the United States, which is included in the Americas geographic region, was $ 291.3 million, $ 388.0 million, and $ 446.0 million for 2024, 2023, and 2022 respectively. No other individual country exceeded 10% of total revenue for any period presented. The Company does not disclose revenue by product category as it does not track sales incentives and other revenue adjustments by product category to report such data. </context> | us-gaap:Revenues |
As of December 31, 2024 and 2023, long-lived assets, which represent net property and equipment, located outside the United States, primarily in Hong Kong and mainland China, were $ 3.5 million and $ 1.6 million, respectively. | text | 3.5 | monetaryItemType | text: <entity> 3.5 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, long-lived assets, which represent net property and equipment, located outside the United States, primarily in Hong Kong and mainland China, were $ 3.5 million and $ 1.6 million, respectively. </context> | us-gaap:AssetsNoncurrent |
As of December 31, 2024 and 2023, long-lived assets, which represent net property and equipment, located outside the United States, primarily in Hong Kong and mainland China, were $ 3.5 million and $ 1.6 million, respectively. | text | 1.6 | monetaryItemType | text: <entity> 1.6 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, long-lived assets, which represent net property and equipment, located outside the United States, primarily in Hong Kong and mainland China, were $ 3.5 million and $ 1.6 million, respectively. </context> | us-gaap:AssetsNoncurrent |
In August 2024, the Company approved a restructuring plan (the Original Restructuring Plan) and in October 2024, the Company approved an amended restructuring plan (the Updated Restructuring Plan). In connection with the Original Restructuring Plan and Updated Restructuring Plan, the Company reduced its global workforce by 25 % compared to its headcount ending Q2 2024, and recorded restructuring charges of $ 18.7 million including $ 12.7 million related to severance and $ 6.0 million of project cancellation costs. | text | 25 | percentItemType | text: <entity> 25 </entity> <entity type> percentItemType </entity type> <context> In August 2024, the Company approved a restructuring plan (the Original Restructuring Plan) and in October 2024, the Company approved an amended restructuring plan (the Updated Restructuring Plan). In connection with the Original Restructuring Plan and Updated Restructuring Plan, the Company reduced its global workforce by 25 % compared to its headcount ending Q2 2024, and recorded restructuring charges of $ 18.7 million including $ 12.7 million related to severance and $ 6.0 million of project cancellation costs. </context> | us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent |
In August 2024, the Company approved a restructuring plan (the Original Restructuring Plan) and in October 2024, the Company approved an amended restructuring plan (the Updated Restructuring Plan). In connection with the Original Restructuring Plan and Updated Restructuring Plan, the Company reduced its global workforce by 25 % compared to its headcount ending Q2 2024, and recorded restructuring charges of $ 18.7 million including $ 12.7 million related to severance and $ 6.0 million of project cancellation costs. | text | 18.7 | monetaryItemType | text: <entity> 18.7 </entity> <entity type> monetaryItemType </entity type> <context> In August 2024, the Company approved a restructuring plan (the Original Restructuring Plan) and in October 2024, the Company approved an amended restructuring plan (the Updated Restructuring Plan). In connection with the Original Restructuring Plan and Updated Restructuring Plan, the Company reduced its global workforce by 25 % compared to its headcount ending Q2 2024, and recorded restructuring charges of $ 18.7 million including $ 12.7 million related to severance and $ 6.0 million of project cancellation costs. </context> | us-gaap:RestructuringCharges |
In August 2024, the Company approved a restructuring plan (the Original Restructuring Plan) and in October 2024, the Company approved an amended restructuring plan (the Updated Restructuring Plan). In connection with the Original Restructuring Plan and Updated Restructuring Plan, the Company reduced its global workforce by 25 % compared to its headcount ending Q2 2024, and recorded restructuring charges of $ 18.7 million including $ 12.7 million related to severance and $ 6.0 million of project cancellation costs. | text | 12.7 | monetaryItemType | text: <entity> 12.7 </entity> <entity type> monetaryItemType </entity type> <context> In August 2024, the Company approved a restructuring plan (the Original Restructuring Plan) and in October 2024, the Company approved an amended restructuring plan (the Updated Restructuring Plan). In connection with the Original Restructuring Plan and Updated Restructuring Plan, the Company reduced its global workforce by 25 % compared to its headcount ending Q2 2024, and recorded restructuring charges of $ 18.7 million including $ 12.7 million related to severance and $ 6.0 million of project cancellation costs. </context> | us-gaap:SeveranceCosts1 |
In August 2024, the Company approved a restructuring plan (the Original Restructuring Plan) and in October 2024, the Company approved an amended restructuring plan (the Updated Restructuring Plan). In connection with the Original Restructuring Plan and Updated Restructuring Plan, the Company reduced its global workforce by 25 % compared to its headcount ending Q2 2024, and recorded restructuring charges of $ 18.7 million including $ 12.7 million related to severance and $ 6.0 million of project cancellation costs. | text | 6.0 | monetaryItemType | text: <entity> 6.0 </entity> <entity type> monetaryItemType </entity type> <context> In August 2024, the Company approved a restructuring plan (the Original Restructuring Plan) and in October 2024, the Company approved an amended restructuring plan (the Updated Restructuring Plan). In connection with the Original Restructuring Plan and Updated Restructuring Plan, the Company reduced its global workforce by 25 % compared to its headcount ending Q2 2024, and recorded restructuring charges of $ 18.7 million including $ 12.7 million related to severance and $ 6.0 million of project cancellation costs. </context> | us-gaap:RestructuringCharges |
In March 2024, the Company approved a restructuring plan to reduce operating costs and drive stronger operating leverage by reducing the Company’s global workforce by approximately 4 % and closing certain office space. Under the first quarter 2024 restructuring plan, the Company recorded restructuring charges of $ 2.3 million related to severance, $ 3.3 million related to a right-of-use asset impairment upon ceasing the use of part of our headquarters campus and $ 0.6 million related to office space charges. The right-of-use asset impairment charge was recorded as a restructuring expense, primarily in the operating expense financial statement line items in the Consolidated Statements of Operations. The unused portion of the Company’s headquarters campus has its own identifiable expenses and is not dependent on other parts of the Company, and thus was considered its own asset group. As a result, the Company impaired the carrying value of the related right-of-use asset to its estimated fair value using the discounted cash flows method. The discounted future cash flows were based on a discount rate based on the weighted-average cost of capital. As of December 31, 2024, the Company expects to incur approximately $ 1.7 million of office space charges associated with the unused portion of our headquarters campus vacated as a result of the first quarter 2024 restructuring plan, which will be incurred over the underlying remaining lease term. | text | 4 | percentItemType | text: <entity> 4 </entity> <entity type> percentItemType </entity type> <context> In March 2024, the Company approved a restructuring plan to reduce operating costs and drive stronger operating leverage by reducing the Company’s global workforce by approximately 4 % and closing certain office space. Under the first quarter 2024 restructuring plan, the Company recorded restructuring charges of $ 2.3 million related to severance, $ 3.3 million related to a right-of-use asset impairment upon ceasing the use of part of our headquarters campus and $ 0.6 million related to office space charges. The right-of-use asset impairment charge was recorded as a restructuring expense, primarily in the operating expense financial statement line items in the Consolidated Statements of Operations. The unused portion of the Company’s headquarters campus has its own identifiable expenses and is not dependent on other parts of the Company, and thus was considered its own asset group. As a result, the Company impaired the carrying value of the related right-of-use asset to its estimated fair value using the discounted cash flows method. The discounted future cash flows were based on a discount rate based on the weighted-average cost of capital. As of December 31, 2024, the Company expects to incur approximately $ 1.7 million of office space charges associated with the unused portion of our headquarters campus vacated as a result of the first quarter 2024 restructuring plan, which will be incurred over the underlying remaining lease term. </context> | us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent |
In March 2024, the Company approved a restructuring plan to reduce operating costs and drive stronger operating leverage by reducing the Company’s global workforce by approximately 4 % and closing certain office space. Under the first quarter 2024 restructuring plan, the Company recorded restructuring charges of $ 2.3 million related to severance, $ 3.3 million related to a right-of-use asset impairment upon ceasing the use of part of our headquarters campus and $ 0.6 million related to office space charges. The right-of-use asset impairment charge was recorded as a restructuring expense, primarily in the operating expense financial statement line items in the Consolidated Statements of Operations. The unused portion of the Company’s headquarters campus has its own identifiable expenses and is not dependent on other parts of the Company, and thus was considered its own asset group. As a result, the Company impaired the carrying value of the related right-of-use asset to its estimated fair value using the discounted cash flows method. The discounted future cash flows were based on a discount rate based on the weighted-average cost of capital. As of December 31, 2024, the Company expects to incur approximately $ 1.7 million of office space charges associated with the unused portion of our headquarters campus vacated as a result of the first quarter 2024 restructuring plan, which will be incurred over the underlying remaining lease term. | text | 2.3 | monetaryItemType | text: <entity> 2.3 </entity> <entity type> monetaryItemType </entity type> <context> In March 2024, the Company approved a restructuring plan to reduce operating costs and drive stronger operating leverage by reducing the Company’s global workforce by approximately 4 % and closing certain office space. Under the first quarter 2024 restructuring plan, the Company recorded restructuring charges of $ 2.3 million related to severance, $ 3.3 million related to a right-of-use asset impairment upon ceasing the use of part of our headquarters campus and $ 0.6 million related to office space charges. The right-of-use asset impairment charge was recorded as a restructuring expense, primarily in the operating expense financial statement line items in the Consolidated Statements of Operations. The unused portion of the Company’s headquarters campus has its own identifiable expenses and is not dependent on other parts of the Company, and thus was considered its own asset group. As a result, the Company impaired the carrying value of the related right-of-use asset to its estimated fair value using the discounted cash flows method. The discounted future cash flows were based on a discount rate based on the weighted-average cost of capital. As of December 31, 2024, the Company expects to incur approximately $ 1.7 million of office space charges associated with the unused portion of our headquarters campus vacated as a result of the first quarter 2024 restructuring plan, which will be incurred over the underlying remaining lease term. </context> | us-gaap:SeveranceCosts1 |
In March 2024, the Company approved a restructuring plan to reduce operating costs and drive stronger operating leverage by reducing the Company’s global workforce by approximately 4 % and closing certain office space. Under the first quarter 2024 restructuring plan, the Company recorded restructuring charges of $ 2.3 million related to severance, $ 3.3 million related to a right-of-use asset impairment upon ceasing the use of part of our headquarters campus and $ 0.6 million related to office space charges. The right-of-use asset impairment charge was recorded as a restructuring expense, primarily in the operating expense financial statement line items in the Consolidated Statements of Operations. The unused portion of the Company’s headquarters campus has its own identifiable expenses and is not dependent on other parts of the Company, and thus was considered its own asset group. As a result, the Company impaired the carrying value of the related right-of-use asset to its estimated fair value using the discounted cash flows method. The discounted future cash flows were based on a discount rate based on the weighted-average cost of capital. As of December 31, 2024, the Company expects to incur approximately $ 1.7 million of office space charges associated with the unused portion of our headquarters campus vacated as a result of the first quarter 2024 restructuring plan, which will be incurred over the underlying remaining lease term. | text | 3.3 | monetaryItemType | text: <entity> 3.3 </entity> <entity type> monetaryItemType </entity type> <context> In March 2024, the Company approved a restructuring plan to reduce operating costs and drive stronger operating leverage by reducing the Company’s global workforce by approximately 4 % and closing certain office space. Under the first quarter 2024 restructuring plan, the Company recorded restructuring charges of $ 2.3 million related to severance, $ 3.3 million related to a right-of-use asset impairment upon ceasing the use of part of our headquarters campus and $ 0.6 million related to office space charges. The right-of-use asset impairment charge was recorded as a restructuring expense, primarily in the operating expense financial statement line items in the Consolidated Statements of Operations. The unused portion of the Company’s headquarters campus has its own identifiable expenses and is not dependent on other parts of the Company, and thus was considered its own asset group. As a result, the Company impaired the carrying value of the related right-of-use asset to its estimated fair value using the discounted cash flows method. The discounted future cash flows were based on a discount rate based on the weighted-average cost of capital. As of December 31, 2024, the Company expects to incur approximately $ 1.7 million of office space charges associated with the unused portion of our headquarters campus vacated as a result of the first quarter 2024 restructuring plan, which will be incurred over the underlying remaining lease term. </context> | us-gaap:RestructuringCostsAndAssetImpairmentCharges |
In March 2024, the Company approved a restructuring plan to reduce operating costs and drive stronger operating leverage by reducing the Company’s global workforce by approximately 4 % and closing certain office space. Under the first quarter 2024 restructuring plan, the Company recorded restructuring charges of $ 2.3 million related to severance, $ 3.3 million related to a right-of-use asset impairment upon ceasing the use of part of our headquarters campus and $ 0.6 million related to office space charges. The right-of-use asset impairment charge was recorded as a restructuring expense, primarily in the operating expense financial statement line items in the Consolidated Statements of Operations. The unused portion of the Company’s headquarters campus has its own identifiable expenses and is not dependent on other parts of the Company, and thus was considered its own asset group. As a result, the Company impaired the carrying value of the related right-of-use asset to its estimated fair value using the discounted cash flows method. The discounted future cash flows were based on a discount rate based on the weighted-average cost of capital. As of December 31, 2024, the Company expects to incur approximately $ 1.7 million of office space charges associated with the unused portion of our headquarters campus vacated as a result of the first quarter 2024 restructuring plan, which will be incurred over the underlying remaining lease term. | text | 0.6 | monetaryItemType | text: <entity> 0.6 </entity> <entity type> monetaryItemType </entity type> <context> In March 2024, the Company approved a restructuring plan to reduce operating costs and drive stronger operating leverage by reducing the Company’s global workforce by approximately 4 % and closing certain office space. Under the first quarter 2024 restructuring plan, the Company recorded restructuring charges of $ 2.3 million related to severance, $ 3.3 million related to a right-of-use asset impairment upon ceasing the use of part of our headquarters campus and $ 0.6 million related to office space charges. The right-of-use asset impairment charge was recorded as a restructuring expense, primarily in the operating expense financial statement line items in the Consolidated Statements of Operations. The unused portion of the Company’s headquarters campus has its own identifiable expenses and is not dependent on other parts of the Company, and thus was considered its own asset group. As a result, the Company impaired the carrying value of the related right-of-use asset to its estimated fair value using the discounted cash flows method. The discounted future cash flows were based on a discount rate based on the weighted-average cost of capital. As of December 31, 2024, the Company expects to incur approximately $ 1.7 million of office space charges associated with the unused portion of our headquarters campus vacated as a result of the first quarter 2024 restructuring plan, which will be incurred over the underlying remaining lease term. </context> | us-gaap:RestructuringCostsAndAssetImpairmentCharges |
In March 2024, the Company approved a restructuring plan to reduce operating costs and drive stronger operating leverage by reducing the Company’s global workforce by approximately 4 % and closing certain office space. Under the first quarter 2024 restructuring plan, the Company recorded restructuring charges of $ 2.3 million related to severance, $ 3.3 million related to a right-of-use asset impairment upon ceasing the use of part of our headquarters campus and $ 0.6 million related to office space charges. The right-of-use asset impairment charge was recorded as a restructuring expense, primarily in the operating expense financial statement line items in the Consolidated Statements of Operations. The unused portion of the Company’s headquarters campus has its own identifiable expenses and is not dependent on other parts of the Company, and thus was considered its own asset group. As a result, the Company impaired the carrying value of the related right-of-use asset to its estimated fair value using the discounted cash flows method. The discounted future cash flows were based on a discount rate based on the weighted-average cost of capital. As of December 31, 2024, the Company expects to incur approximately $ 1.7 million of office space charges associated with the unused portion of our headquarters campus vacated as a result of the first quarter 2024 restructuring plan, which will be incurred over the underlying remaining lease term. | text | 1.7 | monetaryItemType | text: <entity> 1.7 </entity> <entity type> monetaryItemType </entity type> <context> In March 2024, the Company approved a restructuring plan to reduce operating costs and drive stronger operating leverage by reducing the Company’s global workforce by approximately 4 % and closing certain office space. Under the first quarter 2024 restructuring plan, the Company recorded restructuring charges of $ 2.3 million related to severance, $ 3.3 million related to a right-of-use asset impairment upon ceasing the use of part of our headquarters campus and $ 0.6 million related to office space charges. The right-of-use asset impairment charge was recorded as a restructuring expense, primarily in the operating expense financial statement line items in the Consolidated Statements of Operations. The unused portion of the Company’s headquarters campus has its own identifiable expenses and is not dependent on other parts of the Company, and thus was considered its own asset group. As a result, the Company impaired the carrying value of the related right-of-use asset to its estimated fair value using the discounted cash flows method. The discounted future cash flows were based on a discount rate based on the weighted-average cost of capital. As of December 31, 2024, the Company expects to incur approximately $ 1.7 million of office space charges associated with the unused portion of our headquarters campus vacated as a result of the first quarter 2024 restructuring plan, which will be incurred over the underlying remaining lease term. </context> | us-gaap:RestructuringAndRelatedCostExpectedCost1 |
related costs by globally realigning its manufacturing footprint to concentrate production activities in two primary locations: China and Thailand. Under the fourth quarter 2022 restructuring, the Company recorded restructuring charges of $ 8.1 million including $ 7.0 million for camera production line closure costs and $ 1.1 million for related transitional costs to migrate production to the Company’s remaining manufacturing locations. As of December 31, 2023, all restructuring charges related to the fourth quarter 2022 restructuring plan have been paid. | text | 8.1 | monetaryItemType | text: <entity> 8.1 </entity> <entity type> monetaryItemType </entity type> <context> related costs by globally realigning its manufacturing footprint to concentrate production activities in two primary locations: China and Thailand. Under the fourth quarter 2022 restructuring, the Company recorded restructuring charges of $ 8.1 million including $ 7.0 million for camera production line closure costs and $ 1.1 million for related transitional costs to migrate production to the Company’s remaining manufacturing locations. As of December 31, 2023, all restructuring charges related to the fourth quarter 2022 restructuring plan have been paid. </context> | us-gaap:RestructuringCharges |
related costs by globally realigning its manufacturing footprint to concentrate production activities in two primary locations: China and Thailand. Under the fourth quarter 2022 restructuring, the Company recorded restructuring charges of $ 8.1 million including $ 7.0 million for camera production line closure costs and $ 1.1 million for related transitional costs to migrate production to the Company’s remaining manufacturing locations. As of December 31, 2023, all restructuring charges related to the fourth quarter 2022 restructuring plan have been paid. | text | 7.0 | monetaryItemType | text: <entity> 7.0 </entity> <entity type> monetaryItemType </entity type> <context> related costs by globally realigning its manufacturing footprint to concentrate production activities in two primary locations: China and Thailand. Under the fourth quarter 2022 restructuring, the Company recorded restructuring charges of $ 8.1 million including $ 7.0 million for camera production line closure costs and $ 1.1 million for related transitional costs to migrate production to the Company’s remaining manufacturing locations. As of December 31, 2023, all restructuring charges related to the fourth quarter 2022 restructuring plan have been paid. </context> | us-gaap:RestructuringCharges |
related costs by globally realigning its manufacturing footprint to concentrate production activities in two primary locations: China and Thailand. Under the fourth quarter 2022 restructuring, the Company recorded restructuring charges of $ 8.1 million including $ 7.0 million for camera production line closure costs and $ 1.1 million for related transitional costs to migrate production to the Company’s remaining manufacturing locations. As of December 31, 2023, all restructuring charges related to the fourth quarter 2022 restructuring plan have been paid. | text | 1.1 | monetaryItemType | text: <entity> 1.1 </entity> <entity type> monetaryItemType </entity type> <context> related costs by globally realigning its manufacturing footprint to concentrate production activities in two primary locations: China and Thailand. Under the fourth quarter 2022 restructuring, the Company recorded restructuring charges of $ 8.1 million including $ 7.0 million for camera production line closure costs and $ 1.1 million for related transitional costs to migrate production to the Company’s remaining manufacturing locations. As of December 31, 2023, all restructuring charges related to the fourth quarter 2022 restructuring plan have been paid. </context> | us-gaap:RestructuringCharges |
Contract backlog represents the remaining performance obligations that have not yet been recognized as revenue. Backlog includes deferred revenue and amounts that will be invoiced and recognized as revenue in future periods. Total backlog was approximately $ 3.4 billion as of December 31, 2024, of which the Corporation expects to recognize approximatel | text | 3.4 | monetaryItemType | text: <entity> 3.4 </entity> <entity type> monetaryItemType </entity type> <context> Contract backlog represents the remaining performance obligations that have not yet been recognized as revenue. Backlog includes deferred revenue and amounts that will be invoiced and recognized as revenue in future periods. Total backlog was approximately $ 3.4 billion as of December 31, 2024, of which the Corporation expects to recognize approximatel </context> | us-gaap:RevenueRemainingPerformanceObligation |
Timing of revenue recognition and cash collection may result in billed receivables, unbilled receivables (contract assets), and deferred revenue (contract liabilities) on the Consolidated Balance Sheet. The Corporation’s contract assets primarily relate to its rights to consideration for work completed but not billed as of the reporting date. Contract assets are transferred to billed receivables when the rights to consideration become unconditional. This is typical in situations where amounts are billed as work progresses in accordance with agreed-upon contractual terms or upon achievement of contractual milestones. The Corporation’s contract liabilities primarily consist of customer advances received prior to revenue being earned. Revenues recognized for the years ended December 31, 2024, 2023, and 2022 included in the contract liabilities balance at the beginning of the respective years were approximately $ 230 million, $ 195 million, and $ 219 million, respectively. Changes in contract assets and contract liabilities as of December 31, 2024 were not materially impacted by any other factors. Contract assets and contract liabilities are reported in the "Receivables, net" and "Deferred revenue" lines, respectively, within the Consolidated Balance Sheet. | text | 230 | monetaryItemType | text: <entity> 230 </entity> <entity type> monetaryItemType </entity type> <context> Timing of revenue recognition and cash collection may result in billed receivables, unbilled receivables (contract assets), and deferred revenue (contract liabilities) on the Consolidated Balance Sheet. The Corporation’s contract assets primarily relate to its rights to consideration for work completed but not billed as of the reporting date. Contract assets are transferred to billed receivables when the rights to consideration become unconditional. This is typical in situations where amounts are billed as work progresses in accordance with agreed-upon contractual terms or upon achievement of contractual milestones. The Corporation’s contract liabilities primarily consist of customer advances received prior to revenue being earned. Revenues recognized for the years ended December 31, 2024, 2023, and 2022 included in the contract liabilities balance at the beginning of the respective years were approximately $ 230 million, $ 195 million, and $ 219 million, respectively. Changes in contract assets and contract liabilities as of December 31, 2024 were not materially impacted by any other factors. Contract assets and contract liabilities are reported in the "Receivables, net" and "Deferred revenue" lines, respectively, within the Consolidated Balance Sheet. </context> | us-gaap:ContractWithCustomerLiabilityRevenueRecognized |
Timing of revenue recognition and cash collection may result in billed receivables, unbilled receivables (contract assets), and deferred revenue (contract liabilities) on the Consolidated Balance Sheet. The Corporation’s contract assets primarily relate to its rights to consideration for work completed but not billed as of the reporting date. Contract assets are transferred to billed receivables when the rights to consideration become unconditional. This is typical in situations where amounts are billed as work progresses in accordance with agreed-upon contractual terms or upon achievement of contractual milestones. The Corporation’s contract liabilities primarily consist of customer advances received prior to revenue being earned. Revenues recognized for the years ended December 31, 2024, 2023, and 2022 included in the contract liabilities balance at the beginning of the respective years were approximately $ 230 million, $ 195 million, and $ 219 million, respectively. Changes in contract assets and contract liabilities as of December 31, 2024 were not materially impacted by any other factors. Contract assets and contract liabilities are reported in the "Receivables, net" and "Deferred revenue" lines, respectively, within the Consolidated Balance Sheet. | text | 195 | monetaryItemType | text: <entity> 195 </entity> <entity type> monetaryItemType </entity type> <context> Timing of revenue recognition and cash collection may result in billed receivables, unbilled receivables (contract assets), and deferred revenue (contract liabilities) on the Consolidated Balance Sheet. The Corporation’s contract assets primarily relate to its rights to consideration for work completed but not billed as of the reporting date. Contract assets are transferred to billed receivables when the rights to consideration become unconditional. This is typical in situations where amounts are billed as work progresses in accordance with agreed-upon contractual terms or upon achievement of contractual milestones. The Corporation’s contract liabilities primarily consist of customer advances received prior to revenue being earned. Revenues recognized for the years ended December 31, 2024, 2023, and 2022 included in the contract liabilities balance at the beginning of the respective years were approximately $ 230 million, $ 195 million, and $ 219 million, respectively. Changes in contract assets and contract liabilities as of December 31, 2024 were not materially impacted by any other factors. Contract assets and contract liabilities are reported in the "Receivables, net" and "Deferred revenue" lines, respectively, within the Consolidated Balance Sheet. </context> | us-gaap:ContractWithCustomerLiabilityRevenueRecognized |
Timing of revenue recognition and cash collection may result in billed receivables, unbilled receivables (contract assets), and deferred revenue (contract liabilities) on the Consolidated Balance Sheet. The Corporation’s contract assets primarily relate to its rights to consideration for work completed but not billed as of the reporting date. Contract assets are transferred to billed receivables when the rights to consideration become unconditional. This is typical in situations where amounts are billed as work progresses in accordance with agreed-upon contractual terms or upon achievement of contractual milestones. The Corporation’s contract liabilities primarily consist of customer advances received prior to revenue being earned. Revenues recognized for the years ended December 31, 2024, 2023, and 2022 included in the contract liabilities balance at the beginning of the respective years were approximately $ 230 million, $ 195 million, and $ 219 million, respectively. Changes in contract assets and contract liabilities as of December 31, 2024 were not materially impacted by any other factors. Contract assets and contract liabilities are reported in the "Receivables, net" and "Deferred revenue" lines, respectively, within the Consolidated Balance Sheet. | text | 219 | monetaryItemType | text: <entity> 219 </entity> <entity type> monetaryItemType </entity type> <context> Timing of revenue recognition and cash collection may result in billed receivables, unbilled receivables (contract assets), and deferred revenue (contract liabilities) on the Consolidated Balance Sheet. The Corporation’s contract assets primarily relate to its rights to consideration for work completed but not billed as of the reporting date. Contract assets are transferred to billed receivables when the rights to consideration become unconditional. This is typical in situations where amounts are billed as work progresses in accordance with agreed-upon contractual terms or upon achievement of contractual milestones. The Corporation’s contract liabilities primarily consist of customer advances received prior to revenue being earned. Revenues recognized for the years ended December 31, 2024, 2023, and 2022 included in the contract liabilities balance at the beginning of the respective years were approximately $ 230 million, $ 195 million, and $ 219 million, respectively. Changes in contract assets and contract liabilities as of December 31, 2024 were not materially impacted by any other factors. Contract assets and contract liabilities are reported in the "Receivables, net" and "Deferred revenue" lines, respectively, within the Consolidated Balance Sheet. </context> | us-gaap:ContractWithCustomerLiabilityRevenueRecognized |
For the year ended December 31, 2024, the Corporation acquired two businesses for an aggregate purchase price of $ 226 million, net of cash acquired. Such acquisitions contributed $ 8 million of total net sales and $ 1 million of net losses for the year ended December 31, 2024 which are included in the Consolidated Statement of Earnings. | text | two | integerItemType | text: <entity> two </entity> <entity type> integerItemType </entity type> <context> For the year ended December 31, 2024, the Corporation acquired two businesses for an aggregate purchase price of $ 226 million, net of cash acquired. Such acquisitions contributed $ 8 million of total net sales and $ 1 million of net losses for the year ended December 31, 2024 which are included in the Consolidated Statement of Earnings. </context> | us-gaap:NumberOfBusinessesAcquired |
For the year ended December 31, 2024, the Corporation acquired two businesses for an aggregate purchase price of $ 226 million, net of cash acquired. Such acquisitions contributed $ 8 million of total net sales and $ 1 million of net losses for the year ended December 31, 2024 which are included in the Consolidated Statement of Earnings. | text | 226 | monetaryItemType | text: <entity> 226 </entity> <entity type> monetaryItemType </entity type> <context> For the year ended December 31, 2024, the Corporation acquired two businesses for an aggregate purchase price of $ 226 million, net of cash acquired. Such acquisitions contributed $ 8 million of total net sales and $ 1 million of net losses for the year ended December 31, 2024 which are included in the Consolidated Statement of Earnings. </context> | us-gaap:BusinessCombinationConsiderationTransferred1 |
For the year ended December 31, 2024, the Corporation acquired two businesses for an aggregate purchase price of $ 226 million, net of cash acquired. Such acquisitions contributed $ 8 million of total net sales and $ 1 million of net losses for the year ended December 31, 2024 which are included in the Consolidated Statement of Earnings. | text | 8 | monetaryItemType | text: <entity> 8 </entity> <entity type> monetaryItemType </entity type> <context> For the year ended December 31, 2024, the Corporation acquired two businesses for an aggregate purchase price of $ 226 million, net of cash acquired. Such acquisitions contributed $ 8 million of total net sales and $ 1 million of net losses for the year ended December 31, 2024 which are included in the Consolidated Statement of Earnings. </context> | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
For the year ended December 31, 2024, the Corporation acquired two businesses for an aggregate purchase price of $ 226 million, net of cash acquired. Such acquisitions contributed $ 8 million of total net sales and $ 1 million of net losses for the year ended December 31, 2024 which are included in the Consolidated Statement of Earnings. | text | 1 | monetaryItemType | text: <entity> 1 </entity> <entity type> monetaryItemType </entity type> <context> For the year ended December 31, 2024, the Corporation acquired two businesses for an aggregate purchase price of $ 226 million, net of cash acquired. Such acquisitions contributed $ 8 million of total net sales and $ 1 million of net losses for the year ended December 31, 2024 which are included in the Consolidated Statement of Earnings. </context> | us-gaap:NetIncomeLoss |
On April 1, 2024, the Corporation completed the acquisition of WSC for $ 34 million. The Share Purchase Agreement contains representations and warranties customary for a transaction of this type, including a portion of the purchase price deposited in escrow as security for potential indemnification claims against seller. The acquired business, which operates within the Naval & Power segment, is a provider of simulation technology that supports the design, commissioning, and reliable operation of commercial nuclear power generation and process plants. The acquisition is subject to post-closing adjustments with the purchase price allocation not yet complete. | text | 34 | monetaryItemType | text: <entity> 34 </entity> <entity type> monetaryItemType </entity type> <context> On April 1, 2024, the Corporation completed the acquisition of WSC for $ 34 million. The Share Purchase Agreement contains representations and warranties customary for a transaction of this type, including a portion of the purchase price deposited in escrow as security for potential indemnification claims against seller. The acquired business, which operates within the Naval & Power segment, is a provider of simulation technology that supports the design, commissioning, and reliable operation of commercial nuclear power generation and process plants. The acquisition is subject to post-closing adjustments with the purchase price allocation not yet complete. </context> | us-gaap:BusinessCombinationConsiderationTransferred1 |
On December 31, 2024, the Corporation completed the acquisition of Ultra Energy, a subsidiary of Ultra Electronics, for $ 192 million in cash, net of cash acquired. The acquired business, which operates in the Naval & Power segment, is a designer and | text | 192 | monetaryItemType | text: <entity> 192 </entity> <entity type> monetaryItemType </entity type> <context> On December 31, 2024, the Corporation completed the acquisition of Ultra Energy, a subsidiary of Ultra Electronics, for $ 192 million in cash, net of cash acquired. The acquired business, which operates in the Naval & Power segment, is a designer and </context> | us-gaap:BusinessCombinationConsiderationTransferred1 |
The Corporation is either a prime contractor or subcontractor to various agencies of the U.S. Government. Revenues derived directly and indirectly from government sources (primarily the U.S. Government) were 57 % and 56 % of total net sales in 2024 and 2023, respectively. Total receivables due from government sources (primarily the U.S Government) were $ 561.9 million and $ 482.5 million as of December 31, 2024 and 2023, respectively. Government (primarily the U.S. Government) unbilled receivables, net of progress payments, were $ 319.0 million and $ 266.9 million as of December 31, 2024 and 2023, respectively. | text | 57 | percentItemType | text: <entity> 57 </entity> <entity type> percentItemType </entity type> <context> The Corporation is either a prime contractor or subcontractor to various agencies of the U.S. Government. Revenues derived directly and indirectly from government sources (primarily the U.S. Government) were 57 % and 56 % of total net sales in 2024 and 2023, respectively. Total receivables due from government sources (primarily the U.S Government) were $ 561.9 million and $ 482.5 million as of December 31, 2024 and 2023, respectively. Government (primarily the U.S. Government) unbilled receivables, net of progress payments, were $ 319.0 million and $ 266.9 million as of December 31, 2024 and 2023, respectively. </context> | us-gaap:ConcentrationRiskPercentage1 |
The Corporation is either a prime contractor or subcontractor to various agencies of the U.S. Government. Revenues derived directly and indirectly from government sources (primarily the U.S. Government) were 57 % and 56 % of total net sales in 2024 and 2023, respectively. Total receivables due from government sources (primarily the U.S Government) were $ 561.9 million and $ 482.5 million as of December 31, 2024 and 2023, respectively. Government (primarily the U.S. Government) unbilled receivables, net of progress payments, were $ 319.0 million and $ 266.9 million as of December 31, 2024 and 2023, respectively. | text | 56 | percentItemType | text: <entity> 56 </entity> <entity type> percentItemType </entity type> <context> The Corporation is either a prime contractor or subcontractor to various agencies of the U.S. Government. Revenues derived directly and indirectly from government sources (primarily the U.S. Government) were 57 % and 56 % of total net sales in 2024 and 2023, respectively. Total receivables due from government sources (primarily the U.S Government) were $ 561.9 million and $ 482.5 million as of December 31, 2024 and 2023, respectively. Government (primarily the U.S. Government) unbilled receivables, net of progress payments, were $ 319.0 million and $ 266.9 million as of December 31, 2024 and 2023, respectively. </context> | us-gaap:ConcentrationRiskPercentage1 |
The Corporation is either a prime contractor or subcontractor to various agencies of the U.S. Government. Revenues derived directly and indirectly from government sources (primarily the U.S. Government) were 57 % and 56 % of total net sales in 2024 and 2023, respectively. Total receivables due from government sources (primarily the U.S Government) were $ 561.9 million and $ 482.5 million as of December 31, 2024 and 2023, respectively. Government (primarily the U.S. Government) unbilled receivables, net of progress payments, were $ 319.0 million and $ 266.9 million as of December 31, 2024 and 2023, respectively. | text | 561.9 | monetaryItemType | text: <entity> 561.9 </entity> <entity type> monetaryItemType </entity type> <context> The Corporation is either a prime contractor or subcontractor to various agencies of the U.S. Government. Revenues derived directly and indirectly from government sources (primarily the U.S. Government) were 57 % and 56 % of total net sales in 2024 and 2023, respectively. Total receivables due from government sources (primarily the U.S Government) were $ 561.9 million and $ 482.5 million as of December 31, 2024 and 2023, respectively. Government (primarily the U.S. Government) unbilled receivables, net of progress payments, were $ 319.0 million and $ 266.9 million as of December 31, 2024 and 2023, respectively. </context> | us-gaap:AccountsReceivableGross |
The Corporation is either a prime contractor or subcontractor to various agencies of the U.S. Government. Revenues derived directly and indirectly from government sources (primarily the U.S. Government) were 57 % and 56 % of total net sales in 2024 and 2023, respectively. Total receivables due from government sources (primarily the U.S Government) were $ 561.9 million and $ 482.5 million as of December 31, 2024 and 2023, respectively. Government (primarily the U.S. Government) unbilled receivables, net of progress payments, were $ 319.0 million and $ 266.9 million as of December 31, 2024 and 2023, respectively. | text | 482.5 | monetaryItemType | text: <entity> 482.5 </entity> <entity type> monetaryItemType </entity type> <context> The Corporation is either a prime contractor or subcontractor to various agencies of the U.S. Government. Revenues derived directly and indirectly from government sources (primarily the U.S. Government) were 57 % and 56 % of total net sales in 2024 and 2023, respectively. Total receivables due from government sources (primarily the U.S Government) were $ 561.9 million and $ 482.5 million as of December 31, 2024 and 2023, respectively. Government (primarily the U.S. Government) unbilled receivables, net of progress payments, were $ 319.0 million and $ 266.9 million as of December 31, 2024 and 2023, respectively. </context> | us-gaap:AccountsReceivableGross |
The Corporation is either a prime contractor or subcontractor to various agencies of the U.S. Government. Revenues derived directly and indirectly from government sources (primarily the U.S. Government) were 57 % and 56 % of total net sales in 2024 and 2023, respectively. Total receivables due from government sources (primarily the U.S Government) were $ 561.9 million and $ 482.5 million as of December 31, 2024 and 2023, respectively. Government (primarily the U.S. Government) unbilled receivables, net of progress payments, were $ 319.0 million and $ 266.9 million as of December 31, 2024 and 2023, respectively. | text | 319.0 | monetaryItemType | text: <entity> 319.0 </entity> <entity type> monetaryItemType </entity type> <context> The Corporation is either a prime contractor or subcontractor to various agencies of the U.S. Government. Revenues derived directly and indirectly from government sources (primarily the U.S. Government) were 57 % and 56 % of total net sales in 2024 and 2023, respectively. Total receivables due from government sources (primarily the U.S Government) were $ 561.9 million and $ 482.5 million as of December 31, 2024 and 2023, respectively. Government (primarily the U.S. Government) unbilled receivables, net of progress payments, were $ 319.0 million and $ 266.9 million as of December 31, 2024 and 2023, respectively. </context> | us-gaap:ContractWithCustomerAssetNetCurrent |
The Corporation is either a prime contractor or subcontractor to various agencies of the U.S. Government. Revenues derived directly and indirectly from government sources (primarily the U.S. Government) were 57 % and 56 % of total net sales in 2024 and 2023, respectively. Total receivables due from government sources (primarily the U.S Government) were $ 561.9 million and $ 482.5 million as of December 31, 2024 and 2023, respectively. Government (primarily the U.S. Government) unbilled receivables, net of progress payments, were $ 319.0 million and $ 266.9 million as of December 31, 2024 and 2023, respectively. | text | 266.9 | monetaryItemType | text: <entity> 266.9 </entity> <entity type> monetaryItemType </entity type> <context> The Corporation is either a prime contractor or subcontractor to various agencies of the U.S. Government. Revenues derived directly and indirectly from government sources (primarily the U.S. Government) were 57 % and 56 % of total net sales in 2024 and 2023, respectively. Total receivables due from government sources (primarily the U.S Government) were $ 561.9 million and $ 482.5 million as of December 31, 2024 and 2023, respectively. Government (primarily the U.S. Government) unbilled receivables, net of progress payments, were $ 319.0 million and $ 266.9 million as of December 31, 2024 and 2023, respectively. </context> | us-gaap:ContractWithCustomerAssetNetCurrent |
Depreciation expense for the years ended December 31, 2024, 2023, and 2022 was $ 50 million, $ 51 million, and $ 51 million, respectively. | text | 50 | monetaryItemType | text: <entity> 50 </entity> <entity type> monetaryItemType </entity type> <context> Depreciation expense for the years ended December 31, 2024, 2023, and 2022 was $ 50 million, $ 51 million, and $ 51 million, respectively. </context> | us-gaap:Depreciation |
Depreciation expense for the years ended December 31, 2024, 2023, and 2022 was $ 50 million, $ 51 million, and $ 51 million, respectively. | text | 51 | monetaryItemType | text: <entity> 51 </entity> <entity type> monetaryItemType </entity type> <context> Depreciation expense for the years ended December 31, 2024, 2023, and 2022 was $ 50 million, $ 51 million, and $ 51 million, respectively. </context> | us-gaap:Depreciation |
During the year ended December 31, 2024, the Corporation acquired intangible assets of $ 99 million. The Corporation acquired Customer-related intangibles of $ 71 million, Technology of $ 26 million, and Other intangible assets of $ 2 million, which have weighted average amortization periods of 12 years, 15 years, and 3 years, respectively. During the year ended December 31, 2023, the Corporation did not acquire any intangible assets. | text | 99 | monetaryItemType | text: <entity> 99 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2024, the Corporation acquired intangible assets of $ 99 million. The Corporation acquired Customer-related intangibles of $ 71 million, Technology of $ 26 million, and Other intangible assets of $ 2 million, which have weighted average amortization periods of 12 years, 15 years, and 3 years, respectively. During the year ended December 31, 2023, the Corporation did not acquire any intangible assets. </context> | us-gaap:FinitelivedIntangibleAssetsAcquired1 |
During the year ended December 31, 2024, the Corporation acquired intangible assets of $ 99 million. The Corporation acquired Customer-related intangibles of $ 71 million, Technology of $ 26 million, and Other intangible assets of $ 2 million, which have weighted average amortization periods of 12 years, 15 years, and 3 years, respectively. During the year ended December 31, 2023, the Corporation did not acquire any intangible assets. | text | 71 | monetaryItemType | text: <entity> 71 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2024, the Corporation acquired intangible assets of $ 99 million. The Corporation acquired Customer-related intangibles of $ 71 million, Technology of $ 26 million, and Other intangible assets of $ 2 million, which have weighted average amortization periods of 12 years, 15 years, and 3 years, respectively. During the year ended December 31, 2023, the Corporation did not acquire any intangible assets. </context> | us-gaap:FinitelivedIntangibleAssetsAcquired1 |
During the year ended December 31, 2024, the Corporation acquired intangible assets of $ 99 million. The Corporation acquired Customer-related intangibles of $ 71 million, Technology of $ 26 million, and Other intangible assets of $ 2 million, which have weighted average amortization periods of 12 years, 15 years, and 3 years, respectively. During the year ended December 31, 2023, the Corporation did not acquire any intangible assets. | text | 26 | monetaryItemType | text: <entity> 26 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2024, the Corporation acquired intangible assets of $ 99 million. The Corporation acquired Customer-related intangibles of $ 71 million, Technology of $ 26 million, and Other intangible assets of $ 2 million, which have weighted average amortization periods of 12 years, 15 years, and 3 years, respectively. During the year ended December 31, 2023, the Corporation did not acquire any intangible assets. </context> | us-gaap:FinitelivedIntangibleAssetsAcquired1 |
During the year ended December 31, 2024, the Corporation acquired intangible assets of $ 99 million. The Corporation acquired Customer-related intangibles of $ 71 million, Technology of $ 26 million, and Other intangible assets of $ 2 million, which have weighted average amortization periods of 12 years, 15 years, and 3 years, respectively. During the year ended December 31, 2023, the Corporation did not acquire any intangible assets. | text | 2 | monetaryItemType | text: <entity> 2 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2024, the Corporation acquired intangible assets of $ 99 million. The Corporation acquired Customer-related intangibles of $ 71 million, Technology of $ 26 million, and Other intangible assets of $ 2 million, which have weighted average amortization periods of 12 years, 15 years, and 3 years, respectively. During the year ended December 31, 2023, the Corporation did not acquire any intangible assets. </context> | us-gaap:FinitelivedIntangibleAssetsAcquired1 |
Amortization expense for the years ended December 31, 2024, 2023, and 2022 was $ 57 million, $ 65 million, and $ 61 million, respectively. The estimated future amortization expense of intangible assets over the next five years is as follows: | text | 57 | monetaryItemType | text: <entity> 57 </entity> <entity type> monetaryItemType </entity type> <context> Amortization expense for the years ended December 31, 2024, 2023, and 2022 was $ 57 million, $ 65 million, and $ 61 million, respectively. The estimated future amortization expense of intangible assets over the next five years is as follows: </context> | us-gaap:AmortizationOfIntangibleAssets |
Amortization expense for the years ended December 31, 2024, 2023, and 2022 was $ 57 million, $ 65 million, and $ 61 million, respectively. The estimated future amortization expense of intangible assets over the next five years is as follows: | text | 65 | monetaryItemType | text: <entity> 65 </entity> <entity type> monetaryItemType </entity type> <context> Amortization expense for the years ended December 31, 2024, 2023, and 2022 was $ 57 million, $ 65 million, and $ 61 million, respectively. The estimated future amortization expense of intangible assets over the next five years is as follows: </context> | us-gaap:AmortizationOfIntangibleAssets |
Amortization expense for the years ended December 31, 2024, 2023, and 2022 was $ 57 million, $ 65 million, and $ 61 million, respectively. The estimated future amortization expense of intangible assets over the next five years is as follows: | text | 61 | monetaryItemType | text: <entity> 61 </entity> <entity type> monetaryItemType </entity type> <context> Amortization expense for the years ended December 31, 2024, 2023, and 2022 was $ 57 million, $ 65 million, and $ 61 million, respectively. The estimated future amortization expense of intangible assets over the next five years is as follows: </context> | us-gaap:AmortizationOfIntangibleAssets |
The Corporation conducts a portion of its operations from leased facilities, which include manufacturing and service facilities, administrative offices, and warehouses. In addition, the Corporation leases machinery and office equipment under operating leases. Our leases have remaining lease terms ranging from approximately 1 year to 15 years, some of which include options for renewals, escalations, or terminations. Rental expenses for all operating leases amounted to $ 47 million, $ 44 million, and $ 42 million for the years ended December 31, 2024, 2023, and 2022, respectively. | text | 47 | monetaryItemType | text: <entity> 47 </entity> <entity type> monetaryItemType </entity type> <context> The Corporation conducts a portion of its operations from leased facilities, which include manufacturing and service facilities, administrative offices, and warehouses. In addition, the Corporation leases machinery and office equipment under operating leases. Our leases have remaining lease terms ranging from approximately 1 year to 15 years, some of which include options for renewals, escalations, or terminations. Rental expenses for all operating leases amounted to $ 47 million, $ 44 million, and $ 42 million for the years ended December 31, 2024, 2023, and 2022, respectively. </context> | us-gaap:OperatingLeaseCost |
The Corporation conducts a portion of its operations from leased facilities, which include manufacturing and service facilities, administrative offices, and warehouses. In addition, the Corporation leases machinery and office equipment under operating leases. Our leases have remaining lease terms ranging from approximately 1 year to 15 years, some of which include options for renewals, escalations, or terminations. Rental expenses for all operating leases amounted to $ 47 million, $ 44 million, and $ 42 million for the years ended December 31, 2024, 2023, and 2022, respectively. | text | 44 | monetaryItemType | text: <entity> 44 </entity> <entity type> monetaryItemType </entity type> <context> The Corporation conducts a portion of its operations from leased facilities, which include manufacturing and service facilities, administrative offices, and warehouses. In addition, the Corporation leases machinery and office equipment under operating leases. Our leases have remaining lease terms ranging from approximately 1 year to 15 years, some of which include options for renewals, escalations, or terminations. Rental expenses for all operating leases amounted to $ 47 million, $ 44 million, and $ 42 million for the years ended December 31, 2024, 2023, and 2022, respectively. </context> | us-gaap:OperatingLeaseCost |
The Corporation conducts a portion of its operations from leased facilities, which include manufacturing and service facilities, administrative offices, and warehouses. In addition, the Corporation leases machinery and office equipment under operating leases. Our leases have remaining lease terms ranging from approximately 1 year to 15 years, some of which include options for renewals, escalations, or terminations. Rental expenses for all operating leases amounted to $ 47 million, $ 44 million, and $ 42 million for the years ended December 31, 2024, 2023, and 2022, respectively. | text | 42 | monetaryItemType | text: <entity> 42 </entity> <entity type> monetaryItemType </entity type> <context> The Corporation conducts a portion of its operations from leased facilities, which include manufacturing and service facilities, administrative offices, and warehouses. In addition, the Corporation leases machinery and office equipment under operating leases. Our leases have remaining lease terms ranging from approximately 1 year to 15 years, some of which include options for renewals, escalations, or terminations. Rental expenses for all operating leases amounted to $ 47 million, $ 44 million, and $ 42 million for the years ended December 31, 2024, 2023, and 2022, respectively. </context> | us-gaap:OperatingLeaseCost |
instruments as of December 31, 2024, net of debt issuance costs, totaled $ 964 million compared to a carrying value, net of debt issuance costs, of $ 1,046 million. The estimated fair values of the Corporation’s fixed rate debt instruments as of December 31, 2023, net of debt issuance costs, totaled $ 973 million compared to a carrying value, net of debt issuance costs, of $ 1,046 million. | text | 964 | monetaryItemType | text: <entity> 964 </entity> <entity type> monetaryItemType </entity type> <context> instruments as of December 31, 2024, net of debt issuance costs, totaled $ 964 million compared to a carrying value, net of debt issuance costs, of $ 1,046 million. The estimated fair values of the Corporation’s fixed rate debt instruments as of December 31, 2023, net of debt issuance costs, totaled $ 973 million compared to a carrying value, net of debt issuance costs, of $ 1,046 million. </context> | us-gaap:LongtermDebtPercentageBearingFixedInterestAmount |
instruments as of December 31, 2024, net of debt issuance costs, totaled $ 964 million compared to a carrying value, net of debt issuance costs, of $ 1,046 million. The estimated fair values of the Corporation’s fixed rate debt instruments as of December 31, 2023, net of debt issuance costs, totaled $ 973 million compared to a carrying value, net of debt issuance costs, of $ 1,046 million. | text | 1046 | monetaryItemType | text: <entity> 1046 </entity> <entity type> monetaryItemType </entity type> <context> instruments as of December 31, 2024, net of debt issuance costs, totaled $ 964 million compared to a carrying value, net of debt issuance costs, of $ 1,046 million. The estimated fair values of the Corporation’s fixed rate debt instruments as of December 31, 2023, net of debt issuance costs, totaled $ 973 million compared to a carrying value, net of debt issuance costs, of $ 1,046 million. </context> | us-gaap:LongtermDebtPercentageBearingFixedInterestAmount |
instruments as of December 31, 2024, net of debt issuance costs, totaled $ 964 million compared to a carrying value, net of debt issuance costs, of $ 1,046 million. The estimated fair values of the Corporation’s fixed rate debt instruments as of December 31, 2023, net of debt issuance costs, totaled $ 973 million compared to a carrying value, net of debt issuance costs, of $ 1,046 million. | text | 973 | monetaryItemType | text: <entity> 973 </entity> <entity type> monetaryItemType </entity type> <context> instruments as of December 31, 2024, net of debt issuance costs, totaled $ 964 million compared to a carrying value, net of debt issuance costs, of $ 1,046 million. The estimated fair values of the Corporation’s fixed rate debt instruments as of December 31, 2023, net of debt issuance costs, totaled $ 973 million compared to a carrying value, net of debt issuance costs, of $ 1,046 million. </context> | us-gaap:LongtermDebtPercentageBearingFixedInterestAmount |
The Corporation has income tax net operating loss carryforwards related to international operations of $ 21.0 million, of which $ 17.9 million have an indefinite life and $ 3.1 million which expire through 2029. The Corporation has federal and state income tax net loss carryforwards of $ 18.5 million, all of which are net operating losses that expire through 2041. The Corporation has recorded a deferred tax asset of $ 6.4 million, reflecting the benefit of the loss carryforwards related to international and domestic operations. | text | 21.0 | monetaryItemType | text: <entity> 21.0 </entity> <entity type> monetaryItemType </entity type> <context> The Corporation has income tax net operating loss carryforwards related to international operations of $ 21.0 million, of which $ 17.9 million have an indefinite life and $ 3.1 million which expire through 2029. The Corporation has federal and state income tax net loss carryforwards of $ 18.5 million, all of which are net operating losses that expire through 2041. The Corporation has recorded a deferred tax asset of $ 6.4 million, reflecting the benefit of the loss carryforwards related to international and domestic operations. </context> | us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign |
The Corporation has income tax net operating loss carryforwards related to international operations of $ 21.0 million, of which $ 17.9 million have an indefinite life and $ 3.1 million which expire through 2029. The Corporation has federal and state income tax net loss carryforwards of $ 18.5 million, all of which are net operating losses that expire through 2041. The Corporation has recorded a deferred tax asset of $ 6.4 million, reflecting the benefit of the loss carryforwards related to international and domestic operations. | text | 17.9 | monetaryItemType | text: <entity> 17.9 </entity> <entity type> monetaryItemType </entity type> <context> The Corporation has income tax net operating loss carryforwards related to international operations of $ 21.0 million, of which $ 17.9 million have an indefinite life and $ 3.1 million which expire through 2029. The Corporation has federal and state income tax net loss carryforwards of $ 18.5 million, all of which are net operating losses that expire through 2041. The Corporation has recorded a deferred tax asset of $ 6.4 million, reflecting the benefit of the loss carryforwards related to international and domestic operations. </context> | us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration |
The Corporation has income tax net operating loss carryforwards related to international operations of $ 21.0 million, of which $ 17.9 million have an indefinite life and $ 3.1 million which expire through 2029. The Corporation has federal and state income tax net loss carryforwards of $ 18.5 million, all of which are net operating losses that expire through 2041. The Corporation has recorded a deferred tax asset of $ 6.4 million, reflecting the benefit of the loss carryforwards related to international and domestic operations. | text | 3.1 | monetaryItemType | text: <entity> 3.1 </entity> <entity type> monetaryItemType </entity type> <context> The Corporation has income tax net operating loss carryforwards related to international operations of $ 21.0 million, of which $ 17.9 million have an indefinite life and $ 3.1 million which expire through 2029. The Corporation has federal and state income tax net loss carryforwards of $ 18.5 million, all of which are net operating losses that expire through 2041. The Corporation has recorded a deferred tax asset of $ 6.4 million, reflecting the benefit of the loss carryforwards related to international and domestic operations. </context> | us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration |
The Corporation has income tax net operating loss carryforwards related to international operations of $ 21.0 million, of which $ 17.9 million have an indefinite life and $ 3.1 million which expire through 2029. The Corporation has federal and state income tax net loss carryforwards of $ 18.5 million, all of which are net operating losses that expire through 2041. The Corporation has recorded a deferred tax asset of $ 6.4 million, reflecting the benefit of the loss carryforwards related to international and domestic operations. | text | 18.5 | monetaryItemType | text: <entity> 18.5 </entity> <entity type> monetaryItemType </entity type> <context> The Corporation has income tax net operating loss carryforwards related to international operations of $ 21.0 million, of which $ 17.9 million have an indefinite life and $ 3.1 million which expire through 2029. The Corporation has federal and state income tax net loss carryforwards of $ 18.5 million, all of which are net operating losses that expire through 2041. The Corporation has recorded a deferred tax asset of $ 6.4 million, reflecting the benefit of the loss carryforwards related to international and domestic operations. </context> | us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic |
The Corporation has income tax net operating loss carryforwards related to international operations of $ 21.0 million, of which $ 17.9 million have an indefinite life and $ 3.1 million which expire through 2029. The Corporation has federal and state income tax net loss carryforwards of $ 18.5 million, all of which are net operating losses that expire through 2041. The Corporation has recorded a deferred tax asset of $ 6.4 million, reflecting the benefit of the loss carryforwards related to international and domestic operations. | text | 6.4 | monetaryItemType | text: <entity> 6.4 </entity> <entity type> monetaryItemType </entity type> <context> The Corporation has income tax net operating loss carryforwards related to international operations of $ 21.0 million, of which $ 17.9 million have an indefinite life and $ 3.1 million which expire through 2029. The Corporation has federal and state income tax net loss carryforwards of $ 18.5 million, all of which are net operating losses that expire through 2041. The Corporation has recorded a deferred tax asset of $ 6.4 million, reflecting the benefit of the loss carryforwards related to international and domestic operations. </context> | us-gaap:DeferredTaxAssetsOtherTaxCarryforwards |
Management assesses the available positive and negative evidence to estimate if sufficient future taxable income will be generated to utilize the existing deferred tax assets. As of December 31, 2024, the Corporation decreased its valuation allowance to $ 5.0 million, in order to measure only the portion of deferred tax assets that more likely than not will be realized. The amount of the deferred tax asset considered realizable, however, could be adjusted if estimates of future taxable income during the carryforward period are reduced or if objective negative evidence in the form of cumulative losses is no longer present and additional weight may be given to subjective evidence such as projections for growth. | text | 5.0 | monetaryItemType | text: <entity> 5.0 </entity> <entity type> monetaryItemType </entity type> <context> Management assesses the available positive and negative evidence to estimate if sufficient future taxable income will be generated to utilize the existing deferred tax assets. As of December 31, 2024, the Corporation decreased its valuation allowance to $ 5.0 million, in order to measure only the portion of deferred tax assets that more likely than not will be realized. The amount of the deferred tax asset considered realizable, however, could be adjusted if estimates of future taxable income during the carryforward period are reduced or if objective negative evidence in the form of cumulative losses is no longer present and additional weight may be given to subjective evidence such as projections for growth. </context> | us-gaap:DeferredTaxAssetsValuationAllowance |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.